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ABSTRACT OF THE DISSERTATION
Single-Cell Resolution Mechanistic Analyses of Direct Lineage Reprogramming
by
Chuner Guo
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2021
Dr. Samantha Morris, Chair
End-stage organ failures remain a clinical challenge with an unmet need for medical
therapies, with transplantation often being the only curative option. Despite advances in
transplantation outcomes, organ shortage continues to limit the availability of cures to patients in
need. The direct lineage reprogramming of one cell type to another is a promising avenue for
therapy with the following advantages: (1) patient-specific cell sources, (2) direct conversion
without reverting to pluripotency and the associated risk of teratoma formation, and (3) utilization
of the cell type responsible for fibrotic scar formation for the engineering towards the desired cell
fate. Nonetheless, many questions remain in the field, with open issues related to reprogramming
trajectory, efficiency, and specificity. These issues contribute to the limited utility of directly
reprogrammed cells, which oftentimes do not engraft target organs successfully or do so with only
partial functionality.
Of note, many reprogramming strategies are extremely inefficient and produce
heterogeneous cells, with much of the molecular mechanism remaining unknown. A prototypical
engineering approach is reprogramming fibroblasts to induced endoderm progenitors (iEPs). This
lineage conversion is achieved by overexpressing transcription factor Hnf4α, and pioneer

viii

transcription factor Foxa1, 2, or 3. In addition to binding to their gene targets, pioneer transcription
factors can bind compacted chromatin, increase target site accessibility, and recruit cooperative
transcription factors. Pioneer transcription factor binding often precedes transcriptional activation
during development and is thought to be important for establishing competence for developmental
programs.
Interestingly, when iEPs are transplanted into the mouse, they can engraft both liver and
colon, suggesting that they consist of cells with hepatic and intestinal potentials. This is
unsurprising, as both Foxa1/2/3 and Hnf4α are known to be important for endoderm development.
However, not all cells become reprogrammed despite abundant overexpression of reprogramming
factors. This raises important questions regarding the mechanism of reprogramming: What gene
targets are bound by reprogramming factors? Are different outcomes due to differences in binding?
Is pioneer transcription factor binding important for reprogramming success? My hypothesis for
the observed inefficiency and heterogeneity of direct lineage reprogramming is that pioneer
transcription factors bind developmental gene targets inefficiently and variably, influenced by
variable chromatin contexts. To test my hypothesis, I utilized several recent technologies,
including: single-cell RNA-sequencing, to measure transcriptional changes at a resolution needed
to reveal population heterogeneity and reprogramming dynamics; our novel cell tracking approach
‘CellTagging’, to study the dynamics of clonal expansion during reprogramming and to track cell
identity changes in a competitive transplant setting; and the single cell Calling Cards assay, to
record transcription factor binding in different reprogramming trajectories and reveal important
gene regulatory events that influence reprogramming outcomes during the early phases of
reprogramming.

ix

We found that direct reprogramming is characterized by distinct paths: one leading to
successful reprogramming, and a ‘dead-end’ trajectory. Trajectory bifurcation is deterministic
early on, by day 13. This also led to the discovery of Mettl7a1, a putative methyltransferase
identified to be associated with the successful trajectory, which increases reprogramming
efficiency when added to the reprogramming cocktail. We later used CellTag Indexing to track
cells from the reprogramming and dead-end trajectories transplanted into the colon, and discovered
that successfully reprogrammed iEPs engraft via an intestinal stem cell state. Finally, active
enhancer recording in early iEP reprogramming showed that the reprogramming trajectory is
associated with rapid activation of target tissue-specific enhancers in regions that are repressed in
the starting cell type, suggesting that overcoming the chromatin barrier might an important event
for reprogramming outcome.
In summary, I hope to have revealed some insight into the observed inefficiency and
heterogeneity in direct lineage reprogramming. This is a nascent but promising field where much
of the molecular mechanism is still poorly understood, with many more remaining questions to be
answered before advances can be brought from bench to bedside. Further understanding the
mechanism of direct reprogramming, by studying the early actions of pioneer transcription factors,
may reveal additional roadblocks that are limiting reprogramming efficiency, and may one day
lead to novel strategies for improved cell fate engineering and application in regenerative
medicine.
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Chapter 1: Engineering Cell Identity: Gene
Regulatory and Chromatin Contexts
Adapted from:
Engineering Cell Identity: Establishing New Gene Regulatory and Chromatin Landscapes
Chuner Guo and Samantha A. Morris

Guo, C., and Morris, S.A. (2017). Engineering cell identity: establishing new gene regulatory
and chromatin landscapes. Current Opinion in Genetics & Development. 46: 50-57.

© 2017 Elsevier. All Rights Reserved.
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1.1 Abstract
Cellular reprogramming can be achieved by ectopically expressing transcription factors
that directly convert one differentiated cell type into another, bypassing embryonic states. A
number of different cell types have been generated by such “direct lineage reprogramming”
methods, but their practical utility has been limited because, in most protocols, the resulting
populations are often partially differentiated or incompletely specified. Here, we review
mechanisms of lineage reprogramming by pioneer transcription factors, a unique class of
transcriptional regulators that has the capacity to engage with silent chromatin to activate target
gene regulatory networks. We assess the possible barriers to successful reprogramming in the
context of higher-order chromatin landscape, considering how the mechanistic relationship
between nuclear organization and cell identity will be critical to unlocking the full potential of cell
fate engineering.

1.2 Introduction
We now know that, remarkably, a cell can be engineered to adopt another identity. The
field has come a long way since Gurdon’s 1962 landmark study on Xenopus laevis tadpoles derived
by transplanting intestine epithelial nuclei into irradiated eggs (Gurdon, 1962), demonstrating that
a terminally differentiated nucleus still possesses the capability to give rise to a full animal. More
than half a century later, many differentiated cell types can now be engineered to become induced
pluripotent stem cells (iPSCs), independent of an oocyte, using a variety of strategies such as
transcription factor overexpression (Takahashi et al., 2007; Takahashi & Yamanaka, 2006; J. Yu
et al., 2007) and small molecule treatment (Hou et al., 2013; Zhu et al., 2010) (reviewed
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extensively elsewhere (González, Boué, & Izpisúa Belmonte, 2011; Takahashi & Yamanaka, 2016;
Yamanaka, 2012; Y. Zhang, Li, Laurent, & Ding, 2012)). These induced pluripotent stem cells can
then be directed to differentiate into cells of various lineages (including cardiomyocytes (Burridge
et al., 2011; Carvajal-Vergara et al., 2010; Lian et al., 2012), neurons (Dimos et al., 2008), and
pancreatic β cells (Pagliuca et al., 2014; D. Zhang et al., 2009)) for patient-specific disease
modeling, drug screening, and therapy (reviewed in (Avior, Sagi, & Benvenisty, 2016; Trounson
& DeWitt, 2016)). An alternate strategy aims to convert cell identity between two fullydifferentiated states, without reverting to the pluripotent state. One of the trailblazer studies of this
so-called “direct lineage reprogramming” was the MyoD-mediated induction of muscle fate in
various differentiated primary cells and cell lines (R. L. Davis, Weintraub, & Lassar, 1987). It is
now possible to generate cell types of all three germ layers (for example, induced cardiomyocytes
(Ieda et al., 2010), induced neurons (Vierbuchen et al., 2010), induced pancreatic beta cells (Q.
Zhou, Brown, Kanarek, Rajagopal, & Melton, 2008)) from fully differentiated cell types,
expanding the arsenal of strategies available for cell fate engineering.

1.3 Engineering Cell Identity: Are We There Yet?
As new strategies for cell and tissue engineering arise, key questions remain in the field.
One question pertaining to direct lineage reprogramming is whether the process does indeed
directly reprogram cell identity between fully differentiated states. While many published studies
report no intermediate states based on lineage tracing experiments that monitored canonical
progenitor gene expression (Ieda et al., 2010; Q. Zhou et al., 2008), it is possible that non-canonical
intermediates are visited during the process. This possibility is logical, given that many
developmental gene regulatory networks (GRNs) are engaged by the transcription factors used in
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reprogramming, most of which are known to be developmentally important genes themselves
(Morris, 2016). Experimentally, this is supported by recent observations in neurons reprogrammed
directly from fibroblasts, where a fractional identity was observed mid-conversion that was not
accounted for by fibroblast, neuron, or neuronal progenitor identities based on analysis of singlecell RNA-sequencing data (Treutlein et al., 2016). Another example is illustrated in our recent
study of cell type classification by our network biology platform, CellNet, which revealed that the
transcription factor combination previously thought to generate induced hepatocytes (Sekiya &
Suzuki, 2011) in fact generated immature endoderm progenitor cells with broad developmental
potential as well as long-term self-renewal (Morris et al., 2014).
Another key issue to be addressed is the low efficiency of cell identity engineering. Many
protocols are fraught with low reprogramming efficiencies, estimated to range from 0.1%
(Takahashi & Yamanaka, 2006) to 20% (Vierbuchen et al., 2010). Direct lineage reprogramming,
although not without its own advantages as mentioned above, suffers especially because many
starting cell types do not self-renew indefinitely and are therefore difficult to scale up. This poses
a barrier to useful downstream applications such as cell replacement therapy, which often requires
numbers of cells on the order of millions, and can be especially problematic for the generation of
post-mitotic cell types that do not passage via a proliferative intermediate or only transit through
proliferation briefly.
Finally, at the heart of the discussion is the question of whether the engineered cell has
completely adopted the desired identity. While functionally many engineered cells appear to mimic
their target cell types, close inspection of their transcriptomes and epigenomes reveals that cell
identities are oftentimes insufficiently specified, and that starting cell identities often fail to be
fully erased (Cahan et al., 2014; Morris et al., 2014). In the case of induced hepatocytes generated
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by overexpression of Hnf4a and either Foxa1, 2, or 3 (Sekiya & Suzuki, 2011), the converted cells
failed to classify as liver, and were found to possess intestinal signatures, as well as significant
remaining starting fibroblast signatures (Morris et al., 2014). This observed “infidelity” of many
reprogramming strategies may be at least in part due to unrefined reprogramming “recipes”, or
incomplete transcription factor cocktails that fail to engage all GRNs needed to fully establish
identity. The starting cell identity remains perhaps because canonical developmental GRNs, while
engaged and activated by reprogramming factors, may be unable to execute full erasure of the
starting cell identity. Ultimately, to perfectly and precisely engineer cell identities at a desirable
efficiency, it will be important to understand the mechanism by which this is achieved in the
context of gene regulation, i.e., how to turn on appropriate genetic programs and turn off irrelevant
ones, and also importantly, in the context of nuclear organization, i.e., how to reposition the
respective genetic programs amidst current chromatin landscapes.

1.4 Pioneer Transcription Factors Engage Silent Chromatin
to Reprogram Cell Identity
Many reprogramming strategies include the use of one or more transcription factors or
small molecules to activate core GRNs. A common strategy for identifying the best “recipe” is to
simultaneously overexpress a pool of transcription factors known to be of developmental
significance, then subtract one by one from the pool until the minimal set is determined (Ieda et
al., 2010; Takahashi & Yamanaka, 2006; Vierbuchen et al., 2010; Q. Zhou et al., 2008). Many of
these transcription factor recipes include pioneer transcription factors such as OCT4, SOX2, and
KLF4 in the case of iPSCs (Takahashi et al., 2007; Takahashi & Yamanaka, 2006), ASCL1 for
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induced neurons (Vierbuchen et al., 2010), GATA4 for induced cardiomyocytes (Ieda et
al., 2010), and FOXA1/2/3 for induced hepatocytes (Sekiya & Suzuki, 2011) (Fig. 1.1).

Figure 1.1 Selected pioneer transcription factors used in reprogramming fibroblasts to other cell types.

In addition to binding to DNA, pioneer transcription factors are known to have the
capability to bind compacted chromatin, increase target site accessibility, and recruit cooperative
transcription factors to bind (Fig. 1.2, and reviewed in (Iwafuchi-Doi & Zaret, 2014; Morris, 2016;
Zaret & Carroll, 2011)). This initial binding event by pioneer transcription factors often precedes
transcriptional activation during development, and is thought to be important for establishing
competence for additional regulatory events and developmental programs.
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Figure 1.2 Pioneer transcription factor primes compacted chromatin to establish competence. Pioneer
transcription factors can displace linker histones to bind and open locally compacted nucleosomal chromatin. This
priming action increases binding site accessibility and establishes competence for lineage-specific transcriptional
activation, which requires cooperative binding of additional transcription factors.

The FOXA family represent the first pioneer transcription factors illustrated to play
important roles in regulating lineage specification during development. Developmentally, Foxa is
widely expressed during embryogenesis starting around the time of gastrulation in the mouse, most
prominently within the endoderm and its derivatives such as lung, liver, pancreas, and intestine
(Bossard & Zaret, 2000). Remarkably, despite its broad expression pattern during endoderm
development, FOXA specifies cell fates in a context-dependent manner. In liver precursor cells,
FOXA is among the first to bind to the silent albumin (Alb) enhancer, preceding other enhancerbinding factors and transcriptional activation (Cirillo et al., 2002). In the prospective intestinal
endoderm, FOXA expression equips cells with hepatic potential, which is normally inhibited by
the overlying intestinal mesoderm (Bossard & Zaret, 2000). Indeed, FOXA binding is shown to
induce a “poised” chromatin state, priming the enhancers for lineage-specific recruitment of
additional transcription factors and activation of the respective genetic programs (A. Wang et al.,
2015).
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This pioneer activity of FOXA is characterized by its ability to interact with core histone
proteins, displace linker histones, and open compacted chromatin (Cirillo et al., 2002). Structurally,
FOXA’s forkhead domain resembles the globular domain of avian erythrocyte linker histone H5,
a member of the linker histone H1 family (Clark, Halay, Lai, & Burley, 1993). The ability of
FOXA to engage compacted chromatin is key to its pioneering action, which endows competence
for cooperative binding of additional factors, and is required for maintaining accessible
nucleosomes for lineage-specific gene activation (Iwafuchi-Doi et al., 2016).

1.5 Higher Order Chromatin Landscape May Impose a
Barrier to Establishing New Identity
While pioneer transcription factors play a central role in engaging compacted chromatin
and establishing competence, they alone do not appear sufficient to fully convert cells to a new
identity. Even together with other transcription factors determined to be the best “recipe” for
reprogramming, cell identities are often incompletely specified, often at very low efficiencies. This
could be explained by the following:

1. Pioneer transcription factors bind compacted chromatin promiscuously to establish
developmental potential, but additional signals and cues are needed to precisely guide the
cells down developmental trajectories to become fully mature. This is supported by the
unexpected intestinal fate in induced hepatocytes generated by Hnf4a and Foxa1/2/3
overexpression (Morris et al., 2014), as well as the unexpected myogenic fate arising from
neuronal reprogramming using the well-established “on-target” pioneer transcription factor
ASCL1, in the absence of maturation factors MYT1L and BRN2 (Chanda et al., 2014;
8

Treutlein et al., 2016; Wapinski et al., 2013). Furthermore, direct lineage reprogramming
strategies that are carried out in vivo or involve transplantation of engineered cells often
show better specification and maturation of target cell identities (Qian et al., 2012; Q. Zhou
et al., 2008). This is at least in part due to the possibility that the in vivo environment
provides additional signals and cues to aid maturation.
2. Highly repressive chromatin conformation is restrictive to pioneer transcription factor
binding and precludes access to required genetic programs. For example, megabase
heterochromatin domains marked by H3K9me3 in fibroblasts contain genes required for
reprogramming to pluripotency but are initially resistant to binding by OSKM (OCT4,
SOX2, KLF4, MYC) factors (Soufi, Donahue, & Zaret, 2012). This is in agreement with
the hypothesis that high order compaction of chromatin may be largely inaccessible even
for pioneer transcription factors. Indeed, upon transient knockdown of related histone
methyltransferases in fibroblasts, initial binding by OSKM was significantly increased
(Soufi et al., 2012). Furthermore, reprogramming to pluripotency possesses an early
stochastic phase and a late deterministic phase (Buganim et al., 2012), supporting the idea
that initial access to repressive chromatin compartments remains a barrier to entering
deterministic reprogramming. In line with this hypothesis, there is abundant evidence that
chromatin epigenetics can be modulated by small molecules, often to increase
reprogramming efficiencies (Smith, Yang, Liu, & Zhang, 2016; Y. Zhou et al., 2016)
(reviewed in (Soufi, 2014; Xu, Du, & Deng, 2015)). Certain chemicals improve
reprogramming by regulating histone modifications, DNA methylation, or chromatin
remodeling complexes (C. Yu, Liu, Tang, & Ding, 2014), which may be synergizing to the
action of transcription factors.
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Clearly then, genome accessibility is deeply relevant to gene regulation and the control of
cell fate. Consider cell fate reprogramming in the context of the classic Waddington’s epigenetic
landscape model of development, where a cell must traverse uphill from a low valley in order to
dedifferentiate to pluripotency or transdifferentiate to another cell identity (reviewed in (Takahashi,
2012)). This “hill” then acts as an epigenetic barrier that must be overcome when cell fate changes
are being driven by exogenous means. In the context of engineering cell identity, the higher-order
architecture of nuclear organization is likely a component of the epigenetic barrier, where largescale structures such as the megabase heterochromatin domains prevent exogenous factors from
swiftly inducing epigenetic remodeling and transcriptional shifts. In the text below, we will discuss
the higher-order nuclear organization systematically in the context of epigenetic barriers and
strategies to overcome them for cell identity engineering.

1.6 Nuclear Organization Is a Meaningful Component of Cell
Identity
Consider the challenge of packing the entire length of the genome (2 meters) into a nucleus
with the diameter of typically a few microns—the equivalent of ‘packing 40 kilometers of fine
yarn into a tennis ball’ (Alberts et al., 2002). One can imagine that orderly packaging of genetic
material and segregation of the packaged chromatin into different spatial compartments must be
crucial for establishing proper control of gene regulation. Recent advances in chromosome
conformation capture (3C) and other C-technologies have allowed for increasingly high
resolutions at which we can examine genomic interactions, as well as increasingly high
throughputs so that multiple tissue and cell types can be studied simultaneously. Indeed, studies
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Figure 1.3 The nucleus is organized hierarchically. (a) On the chromosomal level, individual chromosomes are
found within distinct chromosome territories (CTs). Active euchromatin and inactive heterochromatin segregate into
subchromosomal compartments A and B. Topologically associating domains (TADs) are seen in both compartments
A and B. TADs are structural units containing sequences that frequently interact with other sequences in the same
TAD. Within TADs are local structures such as loops, which facilitate contact between gene regulatory elements. (b)
Pioneer transcription factors may be incapable of accessing chromatin within compartment B. For example, FOXA
may access relevant developmental GRNs within TADs in liver progenitor cells, where these TADs are positioned
within compartment A. In a fully differentiated cell type of a different lineage such as fibroblasts, FOXA may be
restricted from these GRNs that now reside in compartment B. (c) Nuclear organization is dynamic over
developmental processes. TADs can move across compartments during differentiation, accompanied by the expansion
of compartment B. Gene expression may be downregulated as a TAD moves into compartment B.
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over the past few decades have provided insights into nuclear organization across various cell types
(reviewed in (Bickmore & van Steensel, 2013; Gibcus & Dekker, 2013)).
A bird’s eye view of the chromatin landscape reveals that the nucleus is organized
hierarchically (Fig. 1.3a). At the microscopic level, individual chromosomes occupy distinctive
chromosome territories (CTs) (Cremer & Cremer, 2001). This was confirmed by Hi-C experiments
showing that intrachromosomal loci interacted at a much higher frequency than interchromosomal
loci (Lieberman-Aiden et al., 2009). On a subchromosomal level, we have known that active
euchromatin and inactive heterochromatin spatially segregate into different regions; these regions
were later computationally validated by spatial compartmentalization of Hi-C analysis, and were
then termed compartments A and B (Lieberman-Aiden et al., 2009). The significance of
compartmentalization dynamics to cell identity is illustrated in a study of subchromosomal
compartments across different cell types, where reorganization on the sub-megabase scale was
observed during differentiation of mouse embryonic stem cells (ESCs) to neuronal progenitor cells
(Phillips-Cremins et al., 2013). Extensive A/B compartment switching altering up to 36% of the
compartments was also shown in a similar experiment using Hi-C to interrogate genomic
interactions in human ESCs and four ESC-derived lineages, where an extension of the B
compartment and lineage-specific compartment transitions were observed (Dixon et al., 2015). As
mentioned previously, the repressive chromatin in compartment B may be inaccessible to pioneer
transcription factors such as FOXA, blocking access to targets that may be needed to establish
target cell identity (Fig. 1.3b). Furthermore, the expansion of compartment B during differentiation
may explain the relative inefficiency of direct lineage reprogramming from differentiated cell
types, compared to that of a directed differentiation approach from a pluripotent state.
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Locally, nuclear organization occurs on a scale that facilitates regulation in a cell identityspecific manner (Fig. 1.3a). Chromatin self-interacts to form topologically associating domains
(TADs) with the help of architectural proteins such as CTCF and cohesin (Dixon et al., 2012).
Within TADs, chromatin is further packaged with the aid of architectural proteins, resulting in
local structures termed chromatin loops (Rao et al., 2014). Although TAD boundaries are largely
conserved (Dixon et al., 2012), TAD positioning and local structures within TADs can be dynamic
across cell and tissue types (Schmitt et al., 2016), as well as over developmental processes. During
stem cell differentiation, compartment switching occurs and results in expansion of compartment
B, reflecting the movement of TADs across compartments (Fig. 1.3c) (Dixon et al., 2015; Gibcus
& Dekker, 2013). In the reverse process of reprogramming somatic cells to pluripotency, TADs
and local structures undergo drastic reorganization, leading to the erasure of tissue-specific
compartment configuration and establishment of ESC-like topology; however, early-passage
iPSCs still possess cell origin-dependent structures acquired during reprogramming that do not
represent remnants of somatic memory, alluding to the possibly distinct reprogramming
trajectories that are cell origin-dependent (Krijger et al., 2016). Notably, a more detailed view of
reprogramming to pluripotency focused on regions of key genes revealed local topologies
susceptible to incomplete rewiring, leading to aberrant gene expression, both of which can be
repaired under 2i/LIF culture conditions (Beagan et al., 2016). These two studies of different
resolutions highlight the many levels of nuclear reorganization that occurs during reprogramming.
Further research will shed light on conditions that may improve the precision of cell identity
engineering by ensuring the establishment of the correct chromatin landscape.

1.7 Thoughts and Perspectives
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In summary, current evidence suggests that nuclear organization is non-random. Tissueand cell type-specific interactions occur on various scales, and reorganization of the nucleus takes
place during development. We also know that cell identities are most accurately engineered when
guided down the developmental trajectories by directed differentiation, and that it is often easier
to directly reprogram immature cell types such as embryonic or neonatal fibroblasts compared to
adult fibroblasts. Taken together, we propose that hierarchical refolding of the nucleus is required
for a cell to establish a new identity, and that the best way to do so may be to return to a precursor
state of chromatin organization, i.e., a progenitor or pluripotent state in development, where a large
part of the genome remains accessible to restructuring. It may be infeasible to shut down one
terminally differentiated identity and create a new one in the same process due to the inaccessibility
of target genetic programs that now reside in compartment B. Take the analogy of origami: once
folded, an origami animal cannot simply be molded to adopt another shape, unless one unfolds it
toward earlier stages (Fig. 1.4). Further examination of the chromatin landscapes of partially or
fully engineered cells may reveal roadblocks that are currently limiting the action of
reprogramming factors, as well as targets that can be perturbed to modulate reprogramming
efficiency and fidelity.
It should be noted that many of the observations from studying nuclear organization do not
yet reveal the driving force behind the association between genomic elements, and its mechanistic
relationship with the ultimate functional consequence of gene regulation, i.e., the biology of a cell.
As a recent review on single-cell genomic technologies points out (Tanay & Regev, 2017), we
now have an unprecedented array of tools to turn observations into insights, to translate
phenomenology into a mechanistic understanding of fundamental biology. The resolution afforded
by single-cell technologies also brings forth questions regarding the potential heterogeneity of cells
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Figure 1.4 Establishment of a new cell identity may require a hierarchical reorganization of the chromatin
landscape. Origami, the art of paper folding, is analogous to nuclear organization in the context of establishing cell
identities. The chromatin landscape of one cell is different from another’s (“rhino” vs. “swan”). To convert a paper
rhino into a swan, it is necessary to unfold the rhino such that the paper can be properly refolded into the shape of the
swan, as direct reshaping may be challenging. Analogously, hierarchical reorganization of the nucleus and transit
through an organizational precursor (corresponding to pluripotency or a progenitor state) may be necessary to ensure
proper reprogramming of cell identities.

sharing the same identity. Indeed, recent single-cell Hi-C studies reveal a stochasticity in local
chromatin organization (Flyamer et al., 2017; Stevens et al., 2017). For us cell engineers, it will
be important to elucidate the mechanism responsible for the initiation and execution of chromatin
landscape remodeling that occurs during normal development, which could provide an actionable
toolset to achieve precise and efficient cell identity engineering.
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Chapter 2: Trajectory of Direct Lineage
Reprogramming
Adapted from:
Single-Cell Mapping of Lineage and Identity in Direct Reprogramming

Biddy, B.A., Kong, W., Kamimoto, K., Guo, C., Waye, S.E., Sun, T., and Morris, S.A. (2018).
Single-cell mapping of lineage and identity in direct reprogramming. Nature. 564(7735): 219224.
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2.1 Abstract
Direct lineage reprogramming is the conversion from one fully differentiated cell type to
another. Although considerable advances have been made, reprogramming mechanisms remain
poorly understood. To study transcriptional changes, clonal dynamics, and reprogramming
trajectory at a high resolution given the substantial population heterogeneity during
reprogramming, we employed single-cell RNA-sequencing and ‘CellTagging’, a combinatorial
cell barcoding approach, for parallel capture of clonal history and cell identity. CellTagging and
tracking fibroblasts reprogramming to become induced endoderm progenitors reveal two distinct
reprogramming paths: one resulting in successful reprogramming, and one leading to a ‘dead-end’
state. This trajectory bifurcation is determined early on during lineage conversion. Further analysis
reveals that Mettl7a1, a putative methyltransferase associated with successful reprogramming
outcome, increases reprogramming efficiency when overexpressed alongside reprogramming
factors. Together, these results demonstrate the utility of CellTagging for lineage reconstruction
and highlight deterministic trajectory bifurcation as an important phenomenon of direct lineage
reprogramming.

2.2 Trajectory Reconstruction in Direct Lineage
Reprogramming
Direct lineage reprogramming is a powerful strategy for engineering cell identity by
converting one somatic cell type to another while bypassing pluripotency. However, these
approaches are generally inefficient, often producing heterogeneous populations of cells that do
not fully and accurately recapitulate the target cell type (Cahan et al., 2014; Morris et al., 2014).
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An important task is to study reprogramming heterogeneity, and many advances have been made
using single-cell RNA-sequencing (scRNA-seq) to distinguish and investigate reprogramming
subpopulations (Buganim et al., 2012; Liu et al., 2017; Treutlein et al., 2016). However, it remains
a challenge to assay cell identity without losing lineage information.
Hence, we sought to simultaneously profile cell identity and clonal history in direct
reprogramming, by utilizing ‘CellTagging’, a high-throughput cell tracking method via heritable
lentiviral barcodes. Sequential delivery of random CellTag barcodes and scRNA-seq at multiple
time points during reprogramming enable the construction of multi-level lineage trees. Each
sequential delivery utilizes a distinct CellTag library, differentiated on the basis of a short motif
preceding the random CellTag region, allowing for their demultiplexing after sequencing. We
applied this to an example of direct lineage reprogramming from mouse embryonic fibroblasts
(MEFs) to induced endoderm progenitors (iEPs), an epithelial-like progenitor population that has
both hepatic and intestinal potentials (Morris et al., 2014; Sekiya & Suzuki, 2011). This is a
prototypical example of direct lineage reprogramming, reflecting the low efficiency and specificity
of many cell identity engineering strategies (Cahan et al., 2014; Morris et al., 2014). We reasoned
that lineage reconstruction of fibroblast reprogramming to iEP might provide general insights into
direct lineage reprogramming.
Briefly, to enable lineage reconstruction during direct reprogramming, fibroblasts were
transduced with an initial CellTag library, CellTagMEF, followed by a 48-hour expansion period.
Then, tagged MEFs were split into two biological replicates for independent reprogramming in
parallel via overexpression of Foxa1 and Hnf4α, as previously described (Morris et al., 2014;
Sekiya & Suzuki, 2011). A second CellTag library (CellTagD3) was delivered at the end of the 3-
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day period of transcription factor delivery, followed by a third round (CellTagD13) on day 13, which
coincides with the phenotypic emergence of epithelial-like iEPs.
Throughout the course of reprogramming, cells were collected every 3–7 days over the 28day time window. For each time point, a sample of cells was fixed in methanol for later processing
by scRNA-seq, while the remaining cells were re-plated to enable clonal growth and lineage
reconstruction.
With this approach, we tracked more than 100,000 cells during conversion to iEPs from
day 0 to day 28, revealing two distinct trajectories: one towards successfully reprogramming,
resulting in cells that express epithelial marker Cdh1 and endodermal marker Apoa1 (Fig. 2.1a);
and an alternative trajectory leading to a putative ‘dead-end’ state, where cells diverge from the
successful lineage and re-express some markers of the starting cell type.
Quantitative analysis of clonal and temporal information reveals a clear bifurcation at day
21, when successfully reprogramming clones pass through transition clusters, leading to the
reprogrammed state at day 28; conversely, iEP-depleted clones on the ‘dead-end’ trajectory
bypassed the transition clusters, traversing a different route on day 21, and finally entering a
putative reprogramming ‘dead-end’ state by day 28 (Fig. 2.1b).
To further narrow down potential timing of trajectory determination, we quantified
occupancy of CellTagD13-labelled cells in reprogrammed and dead-end clusters at day 28. This
analysis revealed a high level of reprogramming state restriction for CellTagD13-labelled, clonally
related cells on day 28, where 88 ± 8% of the clones are restricted to one of the two reprogramming
states, indicating that reprogramming outcome is determined by day 13.
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Figure 2.1 Reprogramming to iEPs is characterized by distinct reprogramming trajectories. (a) Successfully
reprogrammed cells express endodermal marker Apoa1. A putative methyltransferase, Mettl7a1, is expressed in
intermediate clusters. (b) Clonal analysis reveals reprogramming trajectory bifurcation, where successfully
reprogramming clones reach the reprogramming state at day 28, while iEP-depleted clones traverse a different
trajectory to a putative ‘dead-end’ state.

Intriguingly, when we analyzed CellTagD3-labelled, clonally related cells that arise from
the same CellTagMEF-labelled, clonally related fibroblast ancestors, we found that they tend to
follow the same reprogramming trajectory, suggesting that reprogramming trajectory becomes
deterministic early on in the process, perhaps within the first few days of induction.
This led us to consider the possibility that an ‘elite’ cell type exists within the
heterogeneous MEF population that is predisposed or primed to be readily reprogrammed. To
20

investigate this possibility, we compared CellTagMEF-labelled, clonally-related cells that were then
split into separate biological replicates for the reprogramming experiment, a tag-and-split approach
that would lead to shared reprogramming outcome if there exists an elite cell group. This analysis
revealed 84 clones that appeared in both replicates, amongst which only 4 clones share the same
reprogramming outcome, arguing against the ‘elite’ cell type model (Biddy et al., 2018).

2.3 Mettl7a1 Improves Reprogramming Efficiency
The trajectory analysis also led us to investigate a potential positive regulator of
reprogramming, Mettl7a1, a putative methyltransferase expressed along the successful
reprogramming trajectory (Fig. 2.1a). METTL3, a related methyltransferase-like protein, catalyzes
N6-methyladenosine (m6A) modification of mRNA, and regulates stem-cell differentiation and
reprogramming to pluripotency (Batista et al., 2014; Chen et al., 2015). We therefore focused on
Mettl7a1 in the context of facilitating reprogramming efficiency.
We generated iEPs under control condition (Foxa1-Hnf4α) or with Mettl7a1 addition
(Foxa1-Hnf4α-Mettl7a1). Mettl7a1 overexpression was confirmed by performing quantitative RTPCR (qRT-PCR) on RNA prepared from cells transduced with control or Mettl7a1 conditions (Fig.
2.2a). Reprogramming was carried out for two weeks; on day 14, cells from both conditions were
collected for assaying by colony formation and scRNA-seq.
Interestingly, we found that addition of Mettl7a1 to the standard Foxa1-Hnf4α
reprogramming cocktail resulted in a twofold increase in E-cadherin-positive iEP colony formation
(Fig. 2.2b), suggesting that Mettl7a1 addition leads to improved reprogramming efficiency.
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Figure 2.2 Mettl7a1 addition to the reprogramming cocktail results in a higher number of reprogrammed cells.
(a) qRT-PCR analysis confirms Mettl7a1 overexpression in cells reprogrammed with the Foxa1-Hnf4α-Mettl7a1
reprogramming cocktail. (b) Colony formation assay comparing cells reprogrammed with control or Mettl7a1 addition
shows an increased number of colonies when Mettl7a1 is added to the reprogramming cocktail. ***, p < 0.001.

We then performed scRNA-seq analysis of cells reprogrammed with control or Mettl7a1
conditions, integrating with the 28-day time course data for reference and validation; this analysis
showed that sampling at day 14 is representative of the full reprogramming time course (Fig. 2.3a).
Focusing on comparing day 14 cells reprogrammed by control and Mettl7a1 conditions (Fig. 2.3b),
we found that Mettl7a1 addition results in higher levels of Apoa1 expression (Fig. 2.3.c) as well
as threefold increase in the number of cells entering the fully reprogrammed state (Fig. 2.3d-e),
confirming the role of Mettl7a1 as a reprogramming facilitator.
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Figure 2.3 Mettl7a1 addition increases reprogramming efficiency. (a) Integrating data from control and Mettl7a1
cells captured on day 14 with the full 28-day time course confirms that day 14 represents a snapshot of the full
reprogramming process. (b, d-e) Mettl7a1 addition leads to more cells reaching the reprogramming state. (c) More
cells reprogrammed with Mettl7a1 addition express higher levels of iEP marker Apoa1. ***, p < 0.001.
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Of note, via clonal analysis based on CellTag expression, we showed that under both
control and Mettl7a1 conditions, the average number of cells per clone did not differ significantly
(Fig. S2.1). Thus, Mettl7a1, rather than expanding existing iEPs, promotes a true increase in
reprogramming efficiency. Together, these findings demonstrate the utility of lineage
reconstruction in uncovering important regulators of reprogramming, providing molecular insights
into reprogramming that serve to improve the outcome of this generally inefficient process.

2.4 Materials and Methods
2.4.1 Mice and derivation of mouse embryonic fibroblasts
MEFs were derived from embryonic day (E)13.5 C57BL/6J embryos. (The Jackson
laboratory: 000664). Heads and visceral organs were removed and the remaining tissue was
minced with a razor blade and then dissociated in a mixture of 0.05% trypsin and 0.25%
collagenase IV (Life Technologies) at 37 °C for 15 min. After passing the cell slurry through a 70μM filter to remove debris, cells were washed and then plated on 0.1% gelatin-coated plates, in
DMEM supplemented with 10% FBS (Gibco), 2 mM L-glutamine and 50 mM β-mercaptoethanol
(Life Technologies). All animal procedures were based on animal care guidelines approved by the
Institutional Animal Care and Use Committee.

2.4.2 Lenti- and Retrovirus Production
Lentiviral particles were produced by transfecting 293T-17 cells (ATCC: CRL-11268)
with the pSMAL-CellTag construct (see below), along with packaging constructs pCMV-dR8.2
dvpr (Addgene plasmid 8455), and pCMV-VSVG (Addgene plasmid 8454). Constructs were titred
by serial dilution on 293T cells. Hnf4a-T2A-Foxa1 and Mettl7a1 were cloned into the pGCDN24

Sam retroviral construct and packaged with pCL-Eco (Novus Biologicals, NBP2-29540), titred on
fibroblasts. We opted to generate a bicistronic Hnf4a-Foxa1 construct, based on the T2A sequence
to increase the consistency of reprogramming via maintenance of exogenous transcription factor
stoichiometry. Virus was collected 48 h and 72 h after transfection and applied to cells immediately
following filtering through a low-protein binding 0.45-μm filter.

2.4.3 Generation of iEPs
Early passage MEFs (<passage 6) were reprogrammed with modifications to the described
protocols (Sekiya & Suzuki, 2011). We modified this protocol, transducing cells every 12 hours
for 3 days, with fresh Hnf4a-T2A-Foxa1 retrovirus in the presence of 4 µg/ml protamine sulfate
(Sigma-Aldrich). These transduced cells were then cultured on 0.1% gelatin-treated plates for 1
week in hepato-medium (DMEM:F-12, supplemented with 10% FBS, 1 µg/ml insulin (SigmaAldrich), 100 nM dexamethasone (Sigma-Aldrich), 10 mM nicotinamide (Sigma-Aldrich), 2 mM
L-glutamine, 50 mM β-mercaptoethanol (Life Technologies), and penicillin–streptomycin,
containing 20 ng/ml epidermal growth factor (Sigma-Aldrich)). After 7 days of culture, the cells
were transferred onto plates coated with 5 μg/cm2 Type I rat collagen (Gibco, A1048301).

2.4.4 Mettl7a1 Reprogramming
Mouse Mettl7a1 (NM 027334, Origene: MC205948) was sub-cloned into the retroviral
vector, pGCDNSam16, and retrovirus was produced as described above. For comparative
reprogramming experiments, MEFs (1.2 × 105 cells per 6-cm plate, in 3 independent biological
replicates) were serially transduced over 72 h (as above), followed by splitting and seeding at
4 × 104 cells per well of a 6-well plate to generate technical replicates. In control experiments,
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virus produced from an empty vector control expressing only GFP was added to the Foxa1-Hnf4a
reprogramming cocktail. In Mettl7a1 experiments, virus produced from the Mettl7a1-IRES-GFP
construct was added to virus containing Hnf4a and Foxa1. Mettl7a1 overexpression was confirmed
by preparing RNA from cells transduced with Foxa1-Hnf4a and Foxa1-Hnf4a-Mettl7a1 using the
RNeasy kit (Qiagen). Following cDNA synthesis (Maxima cDNA synthesis kit, Life Tech),
quantitative reverse transcription with PCR (qRT–PCR) was performed to quantify Mettl7a1
overexpression (TaqMan Probe: Mm03031185_sH, TaqMan qPCR Mastermix, Applied
Biosystems).
Cells were reprogrammed for two weeks, at which point the cells in some wells were
dissociated and fixed in methanol for 10x Genomics-based single-cell analysis (details below).
The remaining wells were processed for colony-formation assays: cells were fixed on the plate
with 4% paraformaldehyde, permeabilized in 0.1% Triton-X100 then blocked with Mouse on
Mouse Elite Peroxidase Kit (Vector PK-2200). Mouse E-cadherin antibody (1:100, BD
Biosciences) was applied for 30 min before washing and processing with the VECTOR VIP
Peroxidase Substrate Kit (Vector SK-4600). Colonies were visualized on a flatbed scanner, adding
heavy cream to each well to increase image contrast. Colonies were counted, using the colony
counter

ImageJ

plugin

(https://imagej-nih-gov.beckerproxy.wustl.edu/ij/plugins/colony-

counter.html). These analyses were blinded.

2.4.5 Single-Cell RNA-Sequencing and Library Preparation
For single-cell library preparation on the 10x Genomics platform, we used: the Chromium
Single Cell 3’ Library and Gel Bead Kit v2 (PN-120237), Chromium Single Cell 3’ Chip kit v2
(PN-120236) and Chromium i7 Multiplex Kit (PN-120262), according to the manufacturer’s
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instructions in the Chromium Single Cell 3’ Reagents Kits V2 User Guide. Just before cell capture,
methanol-fixed cells were placed on ice, spun at 3,000 r.p.m. for 5 min at 4 °C, followed by
resuspension and rehydration in PBS, according to a previously described method (Alles et al.,
2017). Resulting cDNA libraries were quantified on an Agilent Tapestation and sequenced on an
Illumina HiSeq 3000.
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Figure S2.1 Cells reprogrammed with Mettl7a1 addition do not display higher levels of clonal expansion. n.s.,
non-significant.
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3.1 Abstract
High-throughput single-cell assays increasingly require special consideration in
experimental design, sample multiplexing, batch effect removal, and data interpretation. Here, we
describe a lentiviral barcode-based multiplexing approach, CellTag Indexing, which uses
predefined genetic barcodes that are also heritable, enabling cell populations to be tagged, pooled,
and tracked over time in the same experimental replicate. We demonstrate the utility of CellTag
Indexing by sequencing transcriptomes using a variety of cell types, including long-term tracking
of cell engraftment and differentiation in vivo. Together, this presents CellTag Indexing as a
broadly applicable genetic multiplexing tool that is complementary with existing single-cell
technologies.

3.2 Introduction
Single-cell technology is advancing at a rapid pace, providing unique opportunities to
investigate biological systems and processes with unparalleled resolution. As an increasing variety
of assays are being deployed at single-cell resolution, this has presented new challenges for
experimental design and data analysis. Recently, batch effects were shown to drive aberrant
clustering of the same biological sample processed via two different methodologies (Hicks,
Townes, Teng, & Irizarry, 2017), demonstrating how the accuracy of single-cell data analysis can
be confounded by measurement errors. Several algorithms currently exist to support the
computational correction of batch effects (Butler, Hoffman, Smibert, Papalexi, & Satija, 2018;
Haghverdi, Lun, Morgan, & Marioni, 2018; Ritchie et al., 2015; Shaham et al., 2017). These
methods aim to minimize technical artifacts by regressing out known factors of variation during
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single-cell data processing. However, this requires prior knowledge of the specific factors
contributing to batch effects, limiting these approaches. In an alternative strategy, samples are
pooled together and subsequently demultiplexed, based on their natural genetic variation (Kang et
al., 2018), a powerful approach that supports the multiplexing of up to ~20 samples. However, if
the samples are not genetically distinct or are not accompanied by detailed genotypic knowledge,
demultiplexing by genetic variation does not represent a feasible approach. For instance, this
strategy would not be suitable for comparing different experimental groups from the same
individual or animal model where genetic background stays constant.
Recently, several “label-and-pool” approaches have been developed to mark individual
cells of the same sample with a distinct barcode prior to pooling and processing in the same singlecell RNA-sequencing (scRNA-seq) run (Cao et al., 2017; Gaublomme et al., 2018; Gehring, Park,
Chen, Thomson, & Pachter, 2018; McGinnis et al., 2018; Shin, Lee, Lee, & Bang, 2018; Stoeckius
et al., 2018). For example, cells can be tagged with barcoded antibodies (Gaublomme et al., 2018;
Stoeckius et al., 2018), chemically labeled with DNA oligonucleotides (Gehring et al., 2018;
McGinnis et al., 2018), or transiently transfected with DNA oligonucleotides (Shin et al., 2018),
such that sample identifiers for each cell can be read, in parallel with their transcriptomes.
Similarly, several other methods exist to couple genetic perturbations with barcodes (Adamson et
al., 2016; Datlinger et al., 2017; Dixit et al., 2016; Jaitin et al., 2016; A. S. L. Wong et al., 2016),
although these have not been demonstrated to support reliable, large-scale sample multiplexing.
Here, we introduce a methodology to multiplex biological samples via long-term genetic labeling
with heritable virally-delivered barcodes, 'CellTags'. In this approach, defined 8-nucleotide (nt)
CellTag barcodes are expressed as polyadenylated transcripts, captured in standard single-cell
processing protocols. This design permits the indelible labeling and subsequent identification cells
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by sample, in parallel with measurement of their identity and state. In contrast to labeling
approaches based on transient physical interactions at the cell or nuclear surface, CellTag Indexed
cells retain their heritable barcodes for an extended period in vitro and in vivo, supporting longterm cell tracking experiments. This also distinguishes CellTag Indexing as a unique multiplexing
tool in that cell samples can be tagged, mixed and tracked within the same biological replicate,
and processed together to mitigate unwanted biological and technical variation.
Here, we validate CellTag Index-based multiplexing via the labeling and mixing of
genetically distinct populations, demonstrating accurate and efficient demultiplexing of sample
identity. Furthermore, we demonstrate the efficacy of CellTag Indexing for long-term live cell
multiplexing, via the establishment of a unique competitive transplant model. In this context, we
showcase how CellTag Indexing can be used for in vivo multiplexing to precisely quantify
engraftment and differentiation potential of distinct, competing cell populations. Together, this
positions CellTag Indexing as a broadly applicable tool, easily deployed in cell culture- and
transplantation-based assays, that is compatible across different single-cell modalities.

3.3 Genetic Labeling of Biological Samples via CellTag
Indexing
Here, we describe our lentiviral CellTag toolbox for labeling cells with transcribed DNA
barcodes, acting as cell/sample identifiers that can be easily recovered from single transcriptomes.
CellTag Indexing is based on the integration of defined 8-nt barcodes (CellTags), delivered via
lentivirus. In this design, CellTags are positioned in the 3' UTR of the Green Fluorescent Protein
(GFP) gene, followed by an SV40 polyadenylation signal sequence (Fig. 3.1a). Lentivirus carrying
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Figure 3.1 Validation of CellTag Indexing for genetic labeling of biological samples. (a), Schematic of CellTag
Indexing. CellTag barcodes are positioned in the 3’ UTR of a lentiviral GFP construct with a SV40 polyadenylation
signal. Barcoded viruses produced from CellTag constructs are used to transduce the cells to be ‘tagged’. Tagged
cells can then be pooled for single cell profiling. Prior to analysis, cell identity is demultiplexed by our classifier
pipeline: CellTag digital gene expression (DGE) matrix is generated by extracting and counting CellTag sequences
for each cell; the DGE is then collapsed by consensus clustering of the detected CellTags; after filtering and log
normalization, the DGE is processed by dynamic binarization and classification. Classification results can be
visualized as metadata overlaying single transcriptomes projected onto reduced dimensions. (b), Scatter plot of 18,159
transcriptomes from the 2-tag species mixing experiment, classified by 10x Genomics Cell Ranger pipeline into 9,357
single human cells, 7,456 single mouse cells, and 1,346 multiplets based on alignment to the custom hg19-mm10
reference genome. (c), Scatter plot of 18,159 transcriptomes from the 2-tag species mixing experiment, demultiplexed
by CellTag Indexing into 7,510 human cells (CellTagA), 6,397 mouse cells (CellTagB), 1,040 multiplets, and 3,212
non-determined cells. (d), Log-normalized CellTag expression of the 4,673 transcriptomes from the 5-tag species
mixing experiment, demultiplexed into their respective sample identity on the x-axis; CellTag barcodes, y-axis. (e),
Transcriptomes from the 5-tag species mixing experiment projected onto reduced dimensions by t-SNE, visualized
with CellTag classification. CellTagC, CellTagD, CellTagE, and CellTagA label HEK293Ts; CellTagB labels MEFs.
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a defined CellTag is used to transduce and genetically label a sample, where GFP is included in
this design to enable straightforward quantification of transduction efficiency. This results in the
high expression of heritable, polyadenylated CellTag transcripts that are efficiently captured in
standard single-cell library preparation pipelines, allowing for the demultiplexing of original
sample identity in downstream analysis. We previously demonstrated the efficacy of this approach
to label cells with combinations of random CellTags to support lineage tracing in cell fate
reprogramming (Biddy et al., 2018). While this is a powerful approach to track clonally-related
cells, it requires more complex experimental design and significant computational analysis.
Furthermore, only ~50% of labeled cells can be tracked via this method; while this supports highconfidence lineage reconstruction, it is not suited to high-efficiency cell labeling for the purpose
of sample multiplexing. Our goal here was to expand the utility of CellTagging to support sample
multiplexing.
First, to ensure that CellTag Indexing does not perturb cell physiology, we tested the impact
of labeling on a well-characterized lineage reprogramming system, B cell to induced macrophage
reprogramming (Bussmann et al., 2009). We cultured HAFTL pre-B cells and induced
reprogramming to macrophage fate with β-estradiol, as previously described (Bussmann et al.,
2009). One biological replicate was transduced with CellTag lentivirus, while an independent
control replicate, cultured in parallel, was not transduced (Fig. S3.1a). After 72 hours of
reprogramming, the two induced macrophage samples were independently processed for
sequencing, along with a sample of the original, untransduced B cells. This yielded 1,310
CellTagged transcriptomes, 2,849 control transcriptomes, and 972 B cell transcriptomes. We
detected a median of 6 CellTag transcripts per cell in CellTagged transcriptomes (CellTags were
detected in every cell of this sample), and 0 in control transcriptomes (Fig. S3.1b). Clustering and
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visualization (Becht et al., 2019; Butler et al., 2018) of CellTagged and control macrophage
transcriptomes are interspersed with no independent clustering observed, with both clustering
separately from B cells (Figs. S3.1c-d). Additionally, CellTagged and control induced
macrophages exhibit comparable upregulation of macrophage marker expression, accompanied by
similar levels of B cell marker downregulation (Figs. S3.1e). Genome-wide comparison of gene
expression of the two samples shows a strong linear association with an R2 value of 0.98 (Fig.
S3.1f), confirming that CellTag Indexing does not perturb cell identity or physiology. This is in
agreement with our previous study showing that transduction with a random CellTag library does
not influence cell behavior (Biddy et al., 2018).

3.4 Species Mixing of Genetically Distinct Cells Validates
CellTag-Based Multiplexing
To assess the efficacy of CellTag-based multiplexing, we applied it to 'species mixing', an
experiment commonly performed to estimate cell co-encapsulation rates in droplet-based scRNAseq (Macosko et al., 2015). In this experiment, one sample of human HEK293T cells was labeled
with CellTag Index A (CellTagA), and one sample of mouse embryonic fibroblasts (MEFs) was
labeled with CellTag Index B (CellTagB), for 24-48 hours. Transduction efficiency was visualized
by measuring the percentage of GFP-positive cells (~90%, Fig. S3.2a). Labeled cells were pooled,
in equal proportions, and processed together for single-cell library preparation and sequencing,
yielding a total of 18,159 transcriptomes, with 9,357 single human cells (aligning predominantly
to the hg19 genome), 7,456 single mouse cells (aligning predominantly to the mm10 genome), and
1,346 multiplets as classified by 10x Genomics’ Cell Ranger pipeline, based on alignment to the
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custom hg19-mm10 reference genome (Fig. 3.1b, Fig. S3.2b). For the purpose of validation, we
take this classification result as a benchmark for comparison. To assign sample identity based on
CellTag

Index

expression,

we

developed

a

novel

demultiplexing

algorithm

(https://github.com/morris-lab/CellTag-Classifier) (Guo et al., 2019) that examines the expression
distribution of each CellTag Index, followed by a dynamic binarization step to assess each CellTag
Index signal on an individual cell basis (Fig. 3.1a, Fig. S3.2c; see Methods). With this method, we
demultiplexed the pooled transcriptomes into 7,510 human cells (CellTagA), 6,397 mouse cells
(CellTagB), 1,040 multiplets, and 3,212 non-determined cells (Fig. 3.1c, Fig. S3.2d). Overall, our
algorithm successfully classified, or demultiplexed, 82.3% of all transcriptomes. The presence of
non-determined cells is likely due to cells that did not receive sufficient dosage of virus during
CellTag Index transduction. This can be enhanced by increasing virus multiplicity of infection
(MOI) and visualizing the percentage of GFP-expressing cells prior to sequencing, as
demonstrated below. For the purpose of benchmarking, we removed the 3,212 non-determined
cells for comparison with the 10x-based classification (Figs. S3.2e-f). Using Cohen’s kappa as a
measure of agreement between independent observations, we calculated a kappa of 0.814 (Fig.
S3.2g), suggesting that our demultiplexing is in strong agreement with the orthogonal 10x-based
classification. Furthermore, cells designated as multiplets by both 10x and CellTagging
demonstrate a clear increase in the mean numbers of transcripts per cell (Figs. S3.2h-i), suggesting
they do indeed represent multiplets.
To demonstrate the efficacy of CellTag Indexing for multiplexing several biological
samples in one experiment, we conducted additional validation where four samples of HEK293Ts
and one sample MEFs were transduced with five different predefined CellTag Indexes (HEK293Ts:
CellTags C, D, E, and A; MEFs: CellTag B). A total 4,673 cells were sequenced, with an inferred
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doublet rate of 3.6% (see Methods). Overall, CellTag expression is detected in 99.2% of all cells,
reflecting the improved tagging efficiency from an increased MOI. We demultiplexed the
transcriptomes as above, including an additional step to resolve misclassified multiplets (Fig. S3.2c;
see Methods). Overall, 4,558 out of 4,673 transcriptomes, or 97.5% of all transcriptomes, were
successfully classified (Fig. S3.2a). Visualization of the classified transcriptomes by heatmap of
CellTag barcode expression (Fig. 3.1d) and by dimension reduction (Fig. 3.1e, Figs. S3.3b-c)
demonstrates clear segregation between species, suggesting that CellTag indexing can be used to
reliably multiplex numerous samples.

3.5 CellTag Multiplexing Enables Long-Term Tracking of
Cell Potential in an in Vivo Competitive Transplant Model
Current multiplexing methods are based on transient transfection or temporary molecular
interactions with the cell or nucleus surface (Cao et al., 2017; Gaublomme et al., 2018; Gehring et
al., 2018; McGinnis et al., 2018; Shin et al., 2018; Stoeckius et al., 2018). Although relative to
CellTag Indexing, this offers faster labeling of cells, it does not support long-term labeling. Here,
the unique advantage of CellTag-based multiplexing is that the label is heritable, as a result of
stable integration into the cell genome, and can persist for many weeks as we have shown
previously (Biddy et al., 2018). This creates opportunities for the longitudinal analysis of cell
behavior over an extended period. Moreover, since experimental groups can be tagged, mixed and
tracked within the same biological replicate, unwanted biological and technical variation is
minimized. To explore this application of CellTag multiplexing, we applied the method to assess
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rates of cell engraftment and intestinal differentiation potential in an in vivo competitive transplant
model.
We previously reported that MEFs can be directly reprogrammed, via forced expression of
transcription factors, into progenitor-like cells that possess both hepatic and intestinal potential
(Morris et al., 2014; Sekiya & Suzuki, 2011). We demonstrated that these cells, named induced
endoderm progenitors (iEPs), are able to functionally engraft a mouse model of induced colitis
(Morris et al., 2014). Prior to transplant, iEPs possess weak hepatic and intestinal identity, still
partially resembling the fibroblasts they originated from. 12-days after transplant into the mouse
large intestine, iEPs more closely resemble differentiated intestine (Morris et al., 2014). However,
in this study, cell identity was assessed via bulk expression analysis that cannot distinguish
between different intestinal cell types. Therefore, the mechanism of engraftment and
differentiation potential of cells reprogrammed to iEPs remained to be characterized.
Our recent single-cell lineage tracing of fibroblast to iEP reprogramming revealed that this
lineage conversion comprises two distinct trajectories: one path successfully reprogramming to
iEPs, and an alternate path characterized by progression into a ‘dead-end’ state, where fibroblast
identity is re-established (Biddy et al., 2018). Transition along the successful reprogramming
trajectory is accompanied by upregulation of genes such as Apoa1 and Cdh1 (E-cadherin). We
hypothesized that the Apoa1HighEcadHigh iEP cells constitute the subpopulation responsible for our
previously observed colon engraftment (Morris et al., 2014). In this context, CellTag Indexing is
well-suited for tracking and quantifying reprogrammed and dead-end cell differentiation potential
as the barcodes are stably integrated and heritable, making it possible to label cells for long-term
tracing transplantation experiments.
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Figure 3.2 CellTag Indexing for long-term tracking of cells demonstrated in a competitive transplant
experiment. (a), Schematic of iEP generation and enriched into EcadHigh and EcadLow populations by FACS, labeled
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with CellTagA and CellTagB respectively, pooled in equal proportions and transplanted into a mouse model of colonic
injury. Engrafted colon is then processed for single-nucleus RNA-seq. (b), Fluorescent microscopic images of the
lumen of the engrafted colon, showing patches of GFP+ iEPs. Scale bar, 100 μm. (c), H&E stained section of engrafted
colon showing normal intestinal architecture with evidence of epithelial injury. Scale bar, 100 μm. (d), DAPI stained
section of engrafted colon showing GFP+ iEPs in the mucosa. Scale bar, 100 μm. (e), Transcriptomes from three postengraftment colon tissues sequenced and analyzed, visualized by UMAP, revealing 16 clusters. (f), Annotation of the
16 clusters into (a) Lgr5- Lrig1+ intestinal stem cells (ISCs), (b) Lgr5+ ISCs, (c) deep crypt secretory cells, (d)
endothelial cells, (e) enteric neurons, (f) enterocytes, (g) enteroendocrine cells, (h) fibroblasts, (i) goblet cells, (j) iEPs,
(k) immune cells, (i) muscle, (m) Nkain2+ Csmd1+ cells, and (n) Reln+ Prox1+ cells. (g), Marker expression in
annotated cell types.

To test our hypothesis that the Apoa1HighEcadHigh iEP subpopulation harbors intestinal
engraftment and differentiation potential, we first enriched EcadHigh and EcadLow iEP populations
using fluorescence activated cell sorting (FACS). Functional assays confirmed that EcadHigh iEPs
express significantly higher levels of Apoa1 and Cdh1, form larger colonies of reprogrammed iEPs
in culture, and retain their EcadHigh phenotype, relative to their EcadLow counterparts (Fig. S3.4ac). We then labeled sorted EcadHigh iEPs with CellTagA and EcadLow iEPs with CellTagB, followed
by pooling in equal proportions and transplant into a modified mouse model of colonic mucosal
injury (Fukuda et al., 2014) (Fig. 3.2a). Seven days following transplantation, mice were
euthanized and dissected, and the engrafted colons collected for histology and single-nucleus
RNA-sequencing. Microscopic examination of the engrafted tissue reveals iEP engraftment in
discrete patches, located by their GFP expression (Fig. 3.2b). Histology of the cryosectioned
engrafted colon shows the expected tissue architecture with evidence of epithelial injury (Fig. 3.2c),
occasional submucosal iEPs (Fig. 3.2d), and occasional aggregates of iEPs sitting atop of the
damaged epithelium (Fig. S3.4d).
Most intestinal cell recovery protocols focus on harvest of the epithelium, neglecting many
other cell types that constitute the intestine. Given the range of engraftment phenotypes observed
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in our above histology analyses, we considered that iEPs may also differentiate toward nonepithelial cell types. Thus, to capture the full spectrum of intestinal cell identities, we opted to use
whole tissue single-nucleus extraction, over epithelial isolation and digestion, to process the
engrafted colon for RNA-sequencing. Indeed, single-nucleus RNA-sequencing (snRNA-seq) from
three colon samples, post-engraftment, followed by Uniform Manifold Approximation and
Projection (UMAP)-based visualization (Becht et al., 2019) revealed 16 clusters (Fig. 3.2e),
corresponding to a range of different intestinal epithelial cell types. This included intestinal stem
cells (ISCs), enterocytes, deep crypt secretory cells, goblet cells, enteroendocrine cells, as well as
non-epithelial cell types (endothelial cells, muscle, enteric neurons, immune cells, fibroblasts) (Fig.
3.2f). To our knowledge, this is the first dataset of such that profiles large intestinal cell types
beyond the epithelium. Known intestinal markers are observed such as Lgr5, Lrig1, and Smoc2 in
ISCs (Barker et al., 2007; Muñoz et al., 2012; Powell et al., 2012; V. W. Y. Wong et al., 2012),
Reg4 in deep crypt secretory cells (Sasaki et al., 2016), Myt1l, Asic2, and Syt1 in enteric neurons
(Levanti et al., 2011; Memic et al., 2018; Roy-Carson et al., 2017; Vohra et al., 2006), Vil1, Plac8,
and Krt20 in enterocytes (Chan et al., 2009; S. Gao et al., 2018; Moor et al., 2018), Nkx2-2, Chga,
and Tph1 in enteroendocrine cells (Desai et al., 2008; Gross et al., 2016), and Fcgbp, Muc2, and
Clca1 in goblet cells (Johansson, Larsson, & Hansson, 2010; Pelaseyed et al., 2014) (Fig. 3.2g,
Figs. S3.5c-e).
Upon further analysis and literature review, we annotated the ISCs into two populations,
Lgr5+ ISCs (clusters 1 and 6) and Lgr5- Lrig1+ ISCs (cluster 0), based on distinct patterns of
marker expression (Fig. S3.5c). Lrig1, a transmembrane negative regulator of ErbB
signaling(Laederich et al., 2004), is purported to mark a class of ISCs that are phenotypically
distinct from Lgr5+ stem cells in the intestine (Powell et al., 2012; V. W. Y. Wong et al., 2012),
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with additional roles in stem cells of the gastric epithelium (Schweiger et al., 2018) and the
epidermis (K. B. Jensen & Watt, 2006; Kim B. Jensen et al., 2009; Page, Lombard, Ng, Göttgens,
& Jensen, 2013). Lgr5+ ISCs, located in clusters 1 and 6 in this dataset, express high levels of
established intestinal stem cell markers Lgr5 and Smoc2, as well as Lrig1 (Fig. 3.2g, Figs. S3.5ce). In contrast to Lgr5, Lrig1 is more widely expressed, with moderate levels of expression
extending into cluster 0, where Lgr5 expression is absent (Fig. S3.5c). This is consistent with two
independent studies in the small intestine and colon, where Lrig1 was expressed in many crypt
cells, while the highest levels of Lrig1 expression were observed in Lgr5+ stem cells (Powell et al.,
2012; V. W. Y. Wong et al., 2012). Loss of Lrig1 caused crypt expansion in Lrig1-knockout
animals, and three-dimensional intestinal spheres derived from Lrig1-knockout animals matured
into budding organoids in culture without exogenous ErbB ligands in contrast to wild-type samples
(V. W. Y. Wong et al., 2012). Intriguingly, Lrig1 was shown to mark a population of ISCs that
expand and repopulate the colonic crypt upon tissue damage (Powell et al., 2012), although a
distinction was not made regarding whether this could be due to the subpopulation of Lrig1+ cells
that are also Lgr5+.
Of note, two clusters that remain unannotated (cluster 11, enriched for Reln and Prox1;
cluster 14, enriched for Nkain2 and Csmd1) may represent rare or previously unidentified cell
types (Fig. S3.5d). For example, Reln and Prox1 are known for their roles in neuronal migration
(Sentürk, Pfennig, Weiss, Burk, & Acker-Palmer, 2011; Sheldon et al., 1997) and neurogenesis
(Holzmann, Hennchen, & Rohrer, 2015; Iwano, Masuda, Kiyonari, Enomoto, & Matsuzaki, 2012);
we, therefore, speculate that they may mark a peripheral neuronal cell type in cluster 11.
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3.6 Colon Engrafted iEPs Transition Through an Intestinal
Stem Cell State
To identify iEPs within the single nucleus landscape of the engrafted colon, we extracted
and processed CellTag Indexes across all single transcriptomes. Both CellTagA and CellTagB
barcodes were detected in all three post-engraftment samples (Fig. S3.6a), with clear expression
differences between tags (Fig. S3.6b). Projecting CellTagged iEPs onto the UMAP plot revealed
their enrichment in cluster 4 (Figs. 3.a-b), while a moderate number of CellTagged cells are found
in intestinal epithelial clusters such as cluster 0 (Lgr5- Lrig1+ ISCs) and cluster 1 (Lgr5+ ISCs),
expressing ISC markers Lgr5 and Lrig1 (Figs. 3.3c-d, Fig. S3.6c).
Engrafted tissue was harvested in early stages of intestinal regeneration, with the
epithelium still undergoing active repair. We chose this time point in an effort to understand the
mechanism of iEP engraftment. Indeed, in line with this early regeneration period, cluster 4 likely
represents cells in the early stages of engraftment and repair, characterized by expression of both
intestinal and mesenchymal markers (Figs. S3.5d-e). Notably, Grip1, an adaptor protein implicated
in maintaining the epidermal-dermal junction via the Fras1/Frem1 complex (Bladt, Tafuri, Gelkop,
Langille, & Pawson, 2002; Smyth et al., 2004), is among the list of marker genes for cluster 4,
suggesting that cluster 4 might represent an iEP engraftment mechanism via adhesion to the
basement membrane. We next focused on the proportions of fully-reprogrammed EcadHigh iEPs
(labeled by CellTagA) and dead-end EcadLow iEPs (labeled by CellTagB) engrafting the intestine.
We found that 0.687% ± 0.214% of engrafted cells were derived from reprogrammed iEPs whereas
0.413% ± 0.113% of engrafted cells were derived from dead-end iEPs (p = 0.06; Fig. S3.6d). This
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Figure 3.3 CellTag Indexing revealed iEP engraftment and transition through an intestinal stem cell fate. (a),
CellTags identified engrafted iEPs enriched in cluster 4 (early engraftment iEPs) and the main intestinal epithelial
clusters. (b), Density heatmap confirms enrichment of CellTagged cells in the early engraftment iEP cluster and the
main intestinal epithelial cell clusters. (c-d), Stacked bar plots of CellTagged cells show enrichment in clusters 0, 1,
and 4. (e), Permutation test of cluster enrichment or depletion for each CellTag in intestinal clusters show statistically
significant enrichment of EcadHigh/CellTagA cells in cluster 0 (Lgr5- Lrig1+ ISCs, p = 4.03 × 10-5) and cluster 1 (Lgr5+
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ISCs, p = 9.83 × 10-3). Y-axis, negative log10 of p-value for cluster enrichment, log10 of p-value for cluster depletion.
Dotted lines correspond to a p-value of 0.05. (f), RNA velocity analysis shows velocity vectors from iEPs towards
Lgr5- Lrig1+ ISCs, and from the ISC clusters towards the differentiated enterocytes clusters. (g), Subset of velocity
vectors of CellTagged cells confirm transcriptional kinetics of engrafted iEPs in the direction towards intestinal stem
cells.

low percentage was expected given that we aimed to capture a broad range of intestinal
engraftment to provide an unbiased assessment of engraftment.
In our previous study, we observed that iEPs are capable of long-term (7 weeks posttransplant), functional engraftment, where entire crypts are repopulated by iEP-derived cells
(Morris et al., 2014). At that time, we speculated that iEPs transition through an intestinal stem
cell state to support long-term engraftment. Here, considering our hypothesis that fullyreprogrammed EcadHigh iEPs are responsible for this long-term engraftment, we performed a
randomized test that we previously developed to assign statistical significance in cluster occupancy
(Biddy et al., 2018). Here we applied this approach to determine whether reprogrammed and deadend iEPs were more likely to associate with any particular cluster of intestinal cells. We did not
include cluster 4 in this analysis as the colonic epithelium is in the early stages of regeneration,
where we consider cells in this cluster to be superficially attached, and not all these cells will
eventually integrate into the recovered epithelium. Our randomized test revealed that
reprogrammed-EcadHigh/CellTagA cells are significantly more likely to occupy cluster 0 (Lgr5Lrig1+ ISCs, p=4.03×10-5) and cluster 1 (Lgr5+ ISCs, p=9.83×10-3), while CellTagged
reprogrammed and dead-end populations are depleted from non-epithelial cell clusters (Fig. 3.3e).
Together, this suggests that, EcadHigh/CellTagA cells integrate into the regenerating epithelium via
an intestinal stem cell intermediate. Expression of the ISC markers Lgr5 and Lrig1 in engrafted
iEPs supports this observation (Fig. S3.6c). As reported previously, Lrig1+ ISCs expand and
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repopulate the colonic crypt upon tissue damage (Powell et al., 2012), pointing to a potential
mechanism of long-term iEP engraftment in the mouse colon.
To further investigate engraftment mechanics, we conducted RNA velocity analysis (La
Manno et al., 2018) to reveal the transcriptional kinetics of engrafting iEPs. We reasoned that if
these iEPs were differentiating towards intestinal lineages, then transcript kinetics from early iEP
engraftment cluster, cluster 4, should show velocity vectors towards annotated intestinal clusters.
Indeed, RNA velocities projected onto the UMAP clusters show cluster 4 velocities towards the
main intestinal clusters (Fig. 3.3f, Figs. S3.6f-g). Specifically, velocity vectors from the subset of
CellTagged cells show vectors originating from cluster 4 towards cluster 0, and from the intestinal
stem cell pole of the main intestinal clusters towards the more differentiated pole of enterocytes
(Fig. 3.3g). Taken together, here we have demonstrated the utility of CellTag Indexing to multiplex
EcadHigh and EcadLow iEPs for transplantation into the mouse large intestine, suggesting that iEPs
transition through a Lgr5+ and/or Lrig1+ stem cell state to engraft and repopulate the colonic
epithelium, resolving speculation about their engraftment route. Our findings are consistent with
previous reports of iEP differentiation potential and position CellTag Indexing as a powerful longterm tracking and multiplexing tool for scRNA-seq.

3.7 Discussion
Here, we present a broadly applicable toolbox, CellTag Indexing, to label biological
samples for single-cell analysis, where each sample is genetically tagged with a predefined
lentiviral GFP barcode to mark its sample identity. We demonstrate that CellTag Indexing does
not perturb cell physiology, and validate the utility of our multiplexing approach via species
mixing, showing that it can be used to accurately multiplex samples for scRNA-seq, with

47

subsequent demultiplexing at high-efficiency. We showcase the unique feature of this heritable
labeling approach, by tracking cells in a competitive in vivo transplant setting, revealing
reprogrammed cell potential and mechanisms of engraftment while providing internal controls to
mitigate both biological and technical batch effects. CellTag multiplexing is complementary to
current strategies based on transient cell surface interactions for labeling cells immediately prior
to scRNA-seq, yet unique in that CellTag barcodes are stably integrated and heritable through cell
division. The flexible timing of lentiviral barcode transduction, coupled with stable barcode
expression, makes our system uniquely suitable for long-term tracing experiments and transplant
models where temporary tags would not be retained.
CellTag Indexing offers the advantages of minimized technical variation by experimental
design, the ability to multiplex biological samples for competitive transplant, broad compatibility
with various cell types and single cell technologies, long-term barcode expression, streamlined
workflow and library preparation, reduced sequencing cost, and straightforward demultiplexing.
CellTag Indexing is designed for broad applications; its use of lentivirus as a labeling method
represents a commonly used and accessible biological tool with minimal setup costs and reagent
requirements. As lentivirus can transduce both dividing and non-dividing cells, CellTag barcodes
can be introduced into a wide variety of cell types. In terms of estimating labeling efficiency,
CellTag Indexing conveniently utilizes GFP as a barcode carrier, which can act as a visual readout
for transduction efficiency. Generally, CellTag transcripts are abundantly expressed and can be
optionally amplified during library preparation to further increase detection rate.
Importantly, CellTag transcripts can be recovered from the nucleus, extending this
approach to single nucleus RNA-sequencing. Furthermore, cells labeled with CellTag indexes can
be cultured and used in experiments prior to collection for sequencing, for example in the
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competitive transplant assay we demonstrated here where tagged samples act as internal controls
for each other to minimize unwanted biological variation. This is complementary to existing
labeling methods that utilize cell/nuclear surface chemistry or transient transfection for temporary
tagging (Cao et al., 2017; Gaublomme et al., 2018; Gehring et al., 2018; McGinnis et al., 2018;
Shin et al., 2018; Stoeckius et al., 2018), where the labels would be progressively lost in vitro and
in vivo. Additionally, as a future application, we expect that CellTag multiplexing will be
compatible with single-genome-based assays such as single-cell ATAC-seq. In summary, CellTag
Indexing is a broadly-applicable tool complementary to existing methods for cell multiplexing and
tracking, providing a diverse panel of experimental and analytical strategies.

3.8 Materials and Methods
3.8.1 Cell Culture
Mouse embryonic fibroblasts were derived from the C57BL/6J strain (The Jackson
Laboratory 000664). HEK293T and mouse embryonic fibroblasts were cultured in Dulbecco’s
Modified Eagle Medium (Gibco) supplemented with 10% Fetal Bovine Serum (Gibco), 1%
penicillin/streptomycin (Gibco), and 55 μM 2-mercaptoethanol (Gibco). HAFTL pre-B cells were
cultured in RPMI1640 without phenol red (Lonza) supplemented with 10% charcoal/dextrantreated FBS (Hyclone) and 55 μM 2-mercaptoethanol (Gibco) (Bussmann et al., 2009).

3.8.2 Generation of iEPs
Mouse embryonic fibroblasts were converted to iEPs as previously described (Morris et al.,
2014; Sekiya & Suzuki, 2011). Briefly, fibroblasts were prepared from E13.5 embryos, cultured
on gelatin, and serially transduced every 12 hours with Hnf4α-t2a-Foxa1 retrovirus for 5 times
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over the course of 3 days, followed by culture on collagen in hepato-medium, which is DMEM:F12 (Gibco) supplemented with 10% FBS, 1% penicillin/streptomycin, 55 μM 2-mercaptoethanol,
10 mM nicotinamide (Sigma-Aldrich), 100 nM dexamethasone (Sigma-Aldrich), 1 μg/mL insulin
(Sigma-Aldrich), and 20 ng/ml epidermal growth factor (Sigma-Aldrich).

3.8.3 CellTag Barcodes
CellTag lentiviral constructs were generated by introducing an 8bp variable region into the
3’ UTR of GFP in the pSmal plasmid (Lu, Neff, Quake, & Weissman, 2011) using a gBlock gene
fragment

(Integrated

DNA

Technologies)

and

megaprimer

insertion

(https://www.addgene.org/pooled-library/morris-lab-celltag/). Individual clones were picked and
Sanger sequenced to generate predefined barcodes. The specific CellTag barcodes used in this
manuscript are TGCTATAT (CellTagA), GTTGGCTA (CellTagB), AGTTTAGG (CellTagC),
GGTTCACA (CellTagD), TAGAAAGC (CellTagE).

3.8.4 Lenti- and Retrovirus Production
Lentiviruses were produced by transfecting HEK293T cells with lentiviral pSMAL vector
and packing plasmids pCMV-dR8.2 dvpr (Addgene plasmid 8455) and pCMV-VSV-G (Addgene
plasmid 8454) using X-tremeGENE 9 (Sigma-Aldrich). Viruses were collected 48 and 72 hours
after transfection. Retroviruses were similarly produced, with retroviral pGCDNSam vector and
packaging plasmid pCL-Eco (Imgenex).

3.8.5 CellTag Transduction
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CellTag virus-containing supernatant collected from virus-producing HEK293T cells was
kept at 4 °C and used within one week. Prior to transduction, protamine sulfate (Sigma-Aldrich)
was added to the viral solution to a final concentration of 4 µg/ml. Cells were aspirated of media
and the CellTag virus was added to the cells for a 24-hour transduction period. This transduction
was repeated as needed, for a total of 48 hours for HEK293T cells and 72 hours for MEFs in the
5-tag species mixing experiment, and 72 hours for iEPs.

3.8.6 Immunostaining and Quantification
Transduced HEK293T and MEFs were cultured on a 4-chamber culture slide (Falcon) for
24 hr prior to fixation in 4% paraformaldehyde and staining in 300 nM DAPI in PBS. The slide
was then mounted in ProLong Gold Antifade Mountant (Invitrogen). Images were acquired on a
Nikon eclipse Ts2 inverted microscope. For automatic quantification, images of CellTagged HEK
293T and MEF were processed with a custom python script to count GFP positive/negative cells.
The proportion of GFP positive cells was calculated from DAPI and GFP images. First, DAPI
images were transformed into binary images by thresholding fluorescent signal. The threshold
values were determined by the Otsu method. The binary nucleus image was processed by
watershed segmentation to separate individual cell areas completely. Inappropriately sized objects
were filtered to remove noise and doublet cells. The intensity of the GFP signal per individual cell
area was then quantified to distinguish between GFP positive cells and negative cells. These
processes were run with Python 3.6.1 and its libraries: scikit-image 0.13.0, numpy 1.12.1,
matplotlib 2.0.2, seaborn 0.8.1, jupyter 1.0.0.

3.8.7 Mouse Model of Colonic Mucosal Injury
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Using a previously described procedure (Fukuda et al., 2014), we generated colonic
epithelial injury with modifications as followed: C57BL/6 mice were anesthetized with inhaled
isoflurane. A custom-made syringe catheter (consisted of 3-ml syringe (BD #309657), Luer lock
26-gauge 1/2” dispensing needle (GraingerChoice #5FVG9), and polyethylene tubing (Scientific
Commodities, #BB31695-PE/2) cut to approximate 5-cm in length and affixed to the needle) was
used to deliver approximately 1 mL of PBS enema intraluminally via the anal canal, followed by
gentle abdominal massage to promote excretion of excess fecal matter. The luminal space was then
filled with 0.5 mL of 500 mM EDTA/PBS using the custom syringe catheter over the course of
approximately 30 seconds. Mechanical abrasion was performed with Proxabrush cleaners (Sunstar
#872FC) dipped in 500 mM EDTA/PBS, inserted approximately 1 cm into the colon, with 30
rotational movements to gently scratch the luminal surface.

3.8.8 iEP Characterization and Transplantation
8-week iEPs were stained with mouse E-cadherin-APC antibody (10 μL per one million
cells, R&D Systems, FAB7481A) and sorted on a modified Beckman Coulter MoFlo into
EcadHigh and EcadLow populations. Sorted iEPs were plated and cultured as above. Colony
formation assay was performed as previously described(Biddy et al., 2018). For colon engraftment,
CellTagged EcadHigh and EcadLow iEPs were digested into single-cell suspensions. For each
mouse, 0.5 million of EcadHigh iEPs (CellTagA) and 0.5 million of EcadLow iEPs (CellTagB)
were pooled and resuspended in 50 μL of 10% Matrigel on ice. A total of 1 million iEPs was
instilled into the colonic lumen of each mouse by using the custom syringe catheter, after which
the mouse was held vertically head-down for approximately two minutes to prevent immediate
excretion of the infused cell suspension.
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3.8.9 Single-Nucleus RNA-seq Procedure
Single nucleus extraction from tissue was performed as previously described (Wu et al.,
2018). Briefly, engrafted colonic tissues were finely minced with a razor then transferred to a
Dounce tissue homogenizer (Kimble Chase KT885300-0002) in 2 mL of ice-cold Nuclei EZ Lysis
buffer (Sigma #N-3408) supplemented with protease inhibitor (Roche #5892791001) and RNase
inhibitors (Promega #N2615, Thermo Fisher Scientific #AM2696). The tissue was ground 20-30
times with the loose pestle. The homogenate was filtered through a 200-μm cell strainer
(pluriSelect #43-50200) then transferred back to the Dounce homogenizer, ground with the tight
pestle 10-15 times. The homogenate was incubated on ice for 5 minutes with an additional 2 mL
of lysis buffer, then filtered through a 40-μm cell strainer (pluriSelect #43-50040) and centrifuged
at 500 G for 5 min at 4 °C. The incubation and centrifugation steps were repeated one time,
followed by resuspension Nuclei Suspension Buffer (1x PBS, 1% BSA, 0.1% RNase inhibitor)
and filtering through a 5-μm cell strainer (pluriSelect #43-50005). The nuclei were then loaded
onto the 10x Chromium Single Cell Platform for encapsulation and barcoding.

3.8.10 scRNA-seq Procedure
10x Chromium Single Cell 3’ Library & Gel Bead Kit, 10x Chromium Single Cell 3’ Chip
kit, and 10x Chromium i7 Multiplex kit (10x Genomics) were used according to the manufacturer’s
protocols. Libraries were quantified on the Agilent 2200 TapeStation and sequenced on Illumina
HiSeq 2500.

3.8.11 CellTag Demultiplexing
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Details of the CellTag Classifier can be found on the GitHub repository
(https://github.com/morris-lab/CellTag-Classifier) (Guo et al., 2019). Briefly, the CellTag count
matrix

is

extracted

as

previously

described

(Biddy

et

al.,

2018)

(outlined

at

https://github.com/morris-lab/CloneHunter). CellTag sequences are collapsed using Starcode with
the sphere clustering algorithm(Zorita, Cuscó, & Filion, 2015), where CellTags with similar
sequences were collapsed to the centroid CellTag. The collapsed CellTag count matrix is lognormalized, from which the most highly-expressed CellTags across cells are selected. Then, a
dynamic binarization method is applied to assess the existence of each CellTag in each cell, where
a ‘0’ suggests insignificant/unobservable signals and a ‘1’ indicates a significant signal.
Specifically, for each CellTag, we compute the density function D of its expression across all cells.
Then for each cell, we draw 1,000 samples from the density functions D and calculate the
proportion P of samples that are greater than or equal to the expression value being tested:
, where Cij = expression value of CellTag j in Cell i, S = 1,000 sample drawn
from the density curve of CellTag j, Dj. This process is iterated for at least 50 times to make sure
that the samples are representative of the overall density. The cells are then classified to their
corresponding CellTag based on the proportions calculated above by finding the overall minimum
in each proportion matrix. The uniqueness of the minimum does not eliminate the probability for
the cell to be a multiplet. Hence, for cells with a unique minimum, we examine the pair-wise
differences between the minimum tag and other tags using a baseline cutoff of 0.238 learned via
benchmarking and training against orthogonal 10x classification. Finally, the number of multiplets
identified from our pipeline is compared to the expected number derived from 10x Genomics’
Single Cell 3’ Reagents Kit v2 User Guide Rev E (multiplet % = 0.0007589 × number of cells
recovered + 0.0527214). If the number of multiplets exceeds the expected number, the optional

54

multiplet checkpoint is implemented, where the proportion matrix is sorted such that the most
likely multiplets are identified using a cutoff at the quantile of (1.5 * expected num/multiplet). The
remaining cells are then classified to their singlet identities.

3.8.12 scRNA-seq Analysis
The Cell Ranger v.3.0.1 pipeline (https://support.10xgenomics.com/single-cell-geneexpression/software/downloads/latest) was used to process data generated using the 10x
Chromium platform. For alignment of the single-nucleus RNA-seq data, a modified “pre-mRNA”
mm10 reference was used to include reads aligned to introns. The R package Seurat (Butler et al.,
2018) (Version 3) was used for data processing and visualization. For the iEP dataset, we removed
cells with a low number of genes detected (<200), cells with a high number of UMI detected
(>100000), and cells with a high proportion of UMI counts attributed to mitochondrial genes
(>20%). The filtered expression matrix was then normalized and scaled to remove unwanted
sources of variation driven by number of detected UMIs and mitochondrial gene expression.
Linear dimension reduction was performed, followed by canonical correlation analysis to integrate
independent biological replicates, then clustering and visualization via UMAP (Becht et al., 2019).

3.8.13 Assessing Cluster Occupancy by Randomized Testing
A randomized test that we developed previously (Biddy et al., 2018) was used to identify
clusters that are significantly occupied by EcadHigh/EcadLow iEPs. In brief, we calculated the
proportions of CellTagA and CellTagB cells that fall into each cluster, serving as the null
percentages for the two tags. In particular, let n be the number of cells with a CellTag. Let s be the
number of cells without this tag. The two were then pooled together from which we drew n random
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samples without replacement for at least (n+s)/n times such that every possible ending group can
be captured. With each sample drawn, the occupancy of n sampled cells in each cluster was
calculated. A background proportion distribution was then generated based on this resampling
result. We then used the distributions to compute the likelihood of having the null percentage or
higher. Using a p-value of <0.05, we identified the clusters that are enriched for each CellTag.
This randomized test was performed using a python script. We exclude Cluster 4 in this test as it
represents the early engraftment stage. Cell number tested for CellTagA = 66. Cell number tested
for CellTagB = 46. For visualization, enrichment was represented by negative base 10 logarithmic
of the p-value plus 10-5, while depletion was represented by base 10 logarithmic of the p-value
plus 10-5; the addition of 10-5 to the p-value was performed for handling floating-point accuracy.

3.8.14 RNA Velocity Analysis
RNA velocity was analyzed with Velocyto.py (version 0.17.17). The analysis was done
according to the web instruction; http://velocyto.org/velocyto.py/. For the input of single-cell
RNA-seq data, the output files of 10x cellranger pipeline were used. The single cell RNA-seq reads
for each sample were converted into read-counts after distinguishing a spliced or unspliced
transcript. This process was done with command line velocyto API and final products were saved
as loom files. Next, the loom files of each scRNA-seq sample were merged into a single loom file.
The merged loom file was processed with velocyto python API to create the velocyto object. Then
the velocyto object was integrated with UMAP dimensional reduction data and CellTag data which
were produced in the scRNA-seq analysis with Seurat and CellTag demultiplexing process. Next,
the velocyto object was subjected to quality check and filtering process. Genes were filtered by
the mRNA detection level (min_expr_counts=40, min_cells_express=30). After feature selection
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by a velocyto function, the data were normalized by total molecule count. Then velocyto object
was subjected to a series of final data processing process; PCA, k-nn based imputation, velocity
estimation, and shift calculation. Finally, the vectors estimated by RNA velocity was projected on
the UMAP graph.

3.8.15 Availability of Data and Material
All source data including sequencing reads, single-cell expression matrices, and CellTag
classification metadata are available from the Gene Expression Omnibus (GEO) under accession
number

GSE130065.

The

CellTag

demultiplexing

algorithm

is

available

at

https://github.com/morris-lab/CellTag-Classifier (Guo et al., 2019).
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Figure S3.1 CellTag does not interfere with normal cell physiology or reprogramming. (a), Schematic of B-cell
to macrophage reprogramming and CellTagging. (b), A median of 6 CellTag transcripts are detected per cell in
CellTagged transcriptomes (CellTags were detected in all cells of this sample), while none are detected in control
transcriptomes. (c), CellTagged and control macrophages transcriptomes are interspersed with no independent
clustering; both cluster separately from B cells. (d), CellTagged and control macrophages transcriptomes share
indistinguishable cluster composition, both distinct from B cell transcriptomes. (e), CellTagged and control
macrophages transcriptomes have similar macrophage marker expression and downregulate B cell marker expression.
(f), Genome-wide gene expression between CellTagged and control transcriptomes are strongly correlated with an R2
of 0.98.
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Figure S3.2 CellTag classification compared with 10x-based classification the 2-tag species mixing experiment.
(a), Visualization and quantification of GFP expression in DAPI-stained HEK293Ts (top, 95%) and MEFs (bottom,
88%) transduced with CellTag virus for 24-48 hours. Red box, DAPI+ GFP+; white box, DAPI+ GFP-. (b), 10x-based
classification; excluding non-determined cells. (c), Schematic workflow of the dynamic binarization and classification
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framework. (d), CellTag classification; excluding non-determined cells. (e), Log-normalized CellTag count before
and after filtering for non-determined cells. (f), Visual comparison of CellTag and 10x-based classification. (g), Table
comparing CellTag and 10x-based classification, benchmarked using Cohen’s kappa as a measure of agreement.
Unweighted Cohen’s Kappa = 0.814. (h-i), Total transcript count in different groups as classified by 10x- or CellTagbased classification. Dotted bars, first, median, and third quartiles.
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Figure S3.3 CellTag classification in 5-tag species-mixing experiment. (a), CellTag classification of the 5-tag
species mixing experiment into 637 CellTagC (HEK293T), 867 CellTagD (HEK293T), 501 CellTagE (HEK293T),
1,679 CellTagA (HEK293T), 612 CellTagB (MEF), 262 multiplet, and 115 non-determined cells. (b), Expression
pattern of HEK293T marker POU4F1 and MEF marker Pdgfa in mixed transcriptomes projected onto t-SNE. (c),
CellTag classification visualized over transcriptomes projected onto principal component 1 (PC 1) and PC 2.
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Figure S3.4 Successfully reprogrammed, Apoa1HighEcadHigh iEPs can be enriched by sorting by E-cadherin
expression into EcadHigh and EcadLow iEPs. (a), qRT-PCR of EcadHigh and EcadLow iEPs show overexpression of iEP
markers Apoa1 and Cdh1 in EcadHigh iEPs. (b), Quantification of colony formation assay of EcadHigh and EcadLow
iEPs shows that EcadHigh iEPs have a statistically significantly higher colony area as a proportion of total area. Bottom,
threshold images of colonies. EcadHigh iEPs have a 1.44-fold higher colony count compared to EcadLow iEPs. (c),
Sorted EcadHigh and EcadLow iEPs were plated and cultured for one week. Flow cytometry analysis of cultured EcadHigh
and EcadLow iEPs confirms that EcadHigh iEPs retain their EcadHigh phenotype. **, p < 0.01. ****, p < 0.0001. ns, nonsignificant. (d), EcadHigh and EcadLow iEPs were labeled with CellTagA and CellTagB, respectively, and pooled in
equal proportions for transplantation into the mouse colon. Left and Middle, bright field and fluorescent images of
DAPI stained colon section showing aggregated GFP+ iEPs near the surface of the damaged epithelium. Right, H&E
staining of an adjacent section showing epithelial injury and inflammation with numerous lymphocytic infiltrates.
Scale bars, 100 μm.
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Figure S3.5 Single-nucleus RNA-seq of iEP-engrafted colon tissues reveals intestinal cell types. (a), Visualization
of three biological replicates of engrafted colon (rep1, rep2, rep3) integrated into a single dataset, projected onto PC
1 and P C2. (b), Engrafted samples share similar levels of total numbers of transcript and gene detected per cell. (c),
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‘Blended’ feature plots of Lgr5 and Lrig1 expression, showing a pattern of Lrig1 expression partially overlapping
with areas with high Lgr5 expression. (d), Heatmap of intestinal epithelial and non-epithelial marker expression in
annotated cell types (50 cells randomly sampled from each cell type). (e), Additional feature plots of intestinal marker
expression.

65

Figure S3.6 Visualization of additional CellTag and RNA velocity analysis in iEP-engrafted colon. (a), CellTag
classification shows agreement between three biological replicates of engrafted colon (rep1, rep2, rep3). (b), Heatmap
of scaled expression of CellTagA and CellTagB from rep1 shows distinct patterns of expression. (c), 0.687% ± 0.214%
of each post-engraftment sample were derived from EcadHigh/CellTagA cells, whereas 0.413% ± 0.113% were derived
from EcadLow/CellTagB cells. One-sided student’s t-test, p = 0.06. (d), Lgr5 and Lrig1 expression is detected in a
subset of CellTagged cells. (e), Post-engraftment samples share similar transcriptional kinetics with indistinguishable
proportions of spliced and unspliced transcripts. (f), Full vector field of RNA velocity results. (g), Full velocity vectors
of RNA velocity results.
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Chapter 4: Simultaneous Single-Cell Assay of
Gene Expression and Active Enhancers in
Direct Lineage Reprogramming
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4.1 Abstract
Direct lineage reprogramming from one differentiated cell type to another pertains to cell
identity changes that are typically orchestrated by transcription factor overexpression and its
effects exerted on target genes. The resultant alterations in gene regulatory networks underly the
switch from one cell state to another. Current evidence suggests cell identity reprogramming is
non-linear and heterogeneous. Despite advances in reprogramming strategies, the precise
molecular mechanism behind the reprogramming trajectory heterogeneity remains unclear. Here,
we recorded single-cell enhancer activity in parallel with transcriptomics in mouse embryonic
fibroblasts (MEFs) reprogramming to become induced endoderm progenitors (iEPs), a process
known to deterministically bifurcate into a successful reprogramming trajectory and a ‘dead-end’
trajectory. By analyzing enhancer activity in the context of reprogramming trajectory bifurcation,
we revealed that successful reprogramming is associated with early activation of target tissuespecific enhancers in repressive chromatin regions, suggesting that overcoming the chromatin
barrier is an important feature of efficient reprogramming of cell identity.

4.2 Introduction
A wide range of cell types constitutes a complex organism. These cells develop from a
single fertilized embryo and contain the same genetic material, yet they serve widely differing
functions. The identity of a cell may then be defined as its distinct functional characteristics and
capacities that set it apart from many others in a diverse range of tissues. Cell identity is not static,
and can change in the context of normal development, tissue repair and regeneration, pathological
conditions such as metaplasia and cancer, and artificial processes such as reprogramming.
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Given a shared set of genetic material, cells specify their identities under the control of
specific gene regulatory networks (GRNs) that consist of nodes of genes and edges of their
interactions. Interestingly, by forced expression of transcription factors (TFs) that often occupy
regulating central nodes that interact with many target genes in GRNs, we can reprogram a
differentiated cell back to a stem cell identity, or directly reprogram between differentiated
lineages.
A prototypical example of direct lineage reprogramming is the generation of induced
endoderm progenitors (iEPs) from mouse embryonic fibroblasts (MEFs) by overexpression of
pioneer TF Foxa1/2/3 and cooperative TF Hnf4α (Biddy et al., 2018; Morris et al., 2014; Sekiya
& Suzuki, 2011). In this example, a proliferative and epithelial-like cell population arises from the
starting fibroblast pool, giving rise to cells that can functionally engraft mouse liver (Sekiya &
Suzuki, 2011) and colon (Guo et al., 2019; Morris et al., 2014). The colon engraftment of the iEPs
was an unexpected finding, an additional potential to the originally reported hepatic fate of thentermed induced hepatocytes (iHeps) (Sekiya & Suzuki, 2011). This points to the hypothesis that
pioneer TFs such as FOXA may engage broad developmental gene targets promiscuously,
supported by evidence from direct reprogramming to induced neurons via ASCL1, where an
alternative myogenic fate arose unexpectedly in the absence of BRN2 and MYT1L (Treutlein et
al., 2016).
We previously observed that reprogramming to iEPs is heterogeneous, characterized by
distinct trajectories leading to different outcomes: a successful trajectory resulting in cells that
express epithelial marker Cdh1 (E-cadherin) and endodermal marker Apoa1; and a ‘dead-end’
trajectory resulting in cells that diverge from the successful lineage, re-expressing some markers
of the starting cell type. This trajectory bifurcation occurs by day 13 in the reprogramming process.
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Furthermore, clonally related cells arising from the same ancestors from early time points tend to
follow the same reprogramming trajectory, suggesting that reprogramming trajectory becomes
deterministic early on in the process (Biddy et al., 2018). We later showed that E-cadherin-positive,
successful iEPs are the cell population that engraft the colon epithelium via transition through an
intestinal stem cell identity, suggesting that full, functional target organ engraftment is mediated
by a subpopulation of cells arising in this complex, heterogeneous, and asynchronous
reprogramming process (Guo et al., 2019).
A remaining question is then the molecular mechanism underlying the trajectory
determination. In other words, what causes a subset of cells to become successfully reprogrammed,
while others do not? Current evidence suggests gene regulation is highly context dependent.
Recent work analyzing databases of human gene expression and regulation reveals that tissuespecific functions are largely driven by regulatory network connections, rather than solely by
individual TFs or their targets (Sonawane et al., 2017). This points to another important component
of cell identity, which is the chromatin landscape that gene products such as TFs must navigate to
exert their effects on their gene targets (Guo & Morris, 2017).
To investigate the gene regulatory context underlying direct lineage reprogramming to iEPs,
we employed a novel toolbox, single-cell Calling Cards (scCC), that utilizes transposase-mediated
recording of single-cell enhancer activity via the insertion of a self-reporting transposon (SRT)
directed by PiggyBac transposase’s native affinity to BRD4 (Gogol-Döring et al., 2016; Moudgil
et al., 2019), an epigenetic reader known to localize to lineage-specific enhancers during
differentiation and reprogramming to pluripotency (Di Stefano et al., 2016; Lee et al., 2017;
Najafova et al., 2017). The SRT produces a polyadenylated transcript reporting the genomic
location of the binding event, and can be captured on a single-cell resolution in parallel with the

70

cell’s transcriptome (Moudgil et al., 2019). By combining single-cell transcriptomic and enhancer
profiling, we found a subset of genomic regions associated with the successful iEP reprogramming
trajectory that corresponds to enhancer activity in canonical liver tissue. In contrast, the ‘dead-end’
trajectory recorded enhancer activity that does not correspond to either starting or target tissues,
suggesting that off-target aberrant enhancer activation may be associated with the ‘dead-end’ state
of the reprogramming outcome. We demonstrate here the power of combined single-cell
approaches, and provide evidence for the important role that gene regulatory context plays in
directing cell identity.

4.3 PiggyBac Transposase-Mediated Insertion of SelfReporting Transposon Enables Live Recording of Gene
Regulatory Events
The transposon Calling Cards assay is an alternative to ChIP-seq for recording TF binding,
utilizing a transposase fused to a TF that directs transposon insertion near its binding sites. The
inserted transposons act as ‘calling cards’ at the genomic locations of TF binding, allowing for
their recovery from genomic DNA at a later time (H. Wang, Johnston, & Mitra, 2007; H. Wang,
Mayhew, Chen, Johnston, & Mitra, 2012). However, conventional DNA Calling Cards assay is
only compatible with bulk genomic preparations, hence requiring that the sample populations of
interests must be pre-defined and pre-enriched.
The scCC assay was recently developed for mapping TF binding activity in single-cell
resolution while simultaneously capturing gene expression (Moudgil et al., 2019), making it
possible to record and compare TF binding between subpopulations of a heterogeneous biological
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process. By using a novel self-reporting transposon (SRT) construct of the PiggyBac transposon,
recording of active enhancers can be achieved by undirected insertion of the SRT via PiggyBac
transposase’s (PBase) native affinity to epigenetic reader BRD4. It was previously demonstrated
that PBase physically interacts with BRD4 in human CD4 T cells, inserting transposons that colocalize with BRD4-associated sites (Gogol-Döring et al., 2016). With the scCC assay, undirected
PBase insertions in human and mouse cells cluster in peaks with statistically significant enrichment
of BRD4 ChIP-seq signal, validating the approach for identifying BRD4-bound enhancers
(Moudgil et al., 2019). Alternatively, via directed insertion of the SRT using a PBase fused to a
TF of interest, specific TF binding events can be recorded (Moudgil et al., 2019). The inserted
SRT lacks a polyadenylation signal, and therefore produces a ‘self-reporting’ transcript that
extends beyond the PiggyBac terminal repeat into the adjacent genomic region, until a cryptic
polyadenylation signal is reached. The polyadenylated ‘self-reporting’ transcripts can then be
captured alongside other mRNAs via droplet-based scRNA-seq (Fig. 1).
We first tested using SRTs to map TF-directed insertions by generating a fusion
transposase of FOXA2 fused to a hyperactive variant of PiggyBac transposase (FOXA2-HyPBase)
(Moudgil et al., 2019; Yusa, Zhou, Li, Bradley, & Craig, 2011). We transfected 10 replicates of
HEK293 cells with plasmids encoding the FOXA2-HyPBase fusion and SRT-Puro, which contains
a puromycin-resistance gene for selection. For control, we transfected 10 replicates of HEK293
with HyPBase and SRT-Puro. To test SRT recovery on a population level, we extracted RNA in
bulk from each replicated and prepared the libraries as such. We obtained 483,262 insertions for
FOXA2-HyPBase, and 1,180,329 insertions for HyPBase, from which 9867 peaks were called.
Peak annotation shows enrichment for intron and intergenic regions, with a small subset annotated
as promoters (Fig. S4.1a). As expected, peaks are enriched around transcription start sites (TSS)
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Figure 4.1 A ‘self-reporting’ transposon (SRT) construct enables the recording and reporting of transcription
factor binding events in parallel with transcriptome measurements.

(Fig. S4.1b). Motif discovery analysis revealed that the top de novo motif sequence (Fig. S4.1c)
highly resembles known FOXA motifs, which are also enriched in the peaks (Fig. S4.1d) and
around TSS (Fig. S4.1e).
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Next, we sought to test plasmid delivery into our starting cell type, MEFs, that would allow
for scCC recording within a limited time window early in reprogramming from MEFs to iEPs. We
electroporated MEFs with a plasmid encoding dsRed, and found that expression of the transfected
plasmid is transient, within a one-week window (Fig. S4.2a), with maximal expression around
days 1-2 (Fig. S4.2b).
To test SRT recovery on a single-cell level, we then applied this electroporation condition
to deliver plasmids encoding either HyPBase (for undirected insertions) or FOXA2-hyPBase (for
FOXA2-directed insertions), along with SRT-tdTomato, into to MEFs that were then transduced
with Foxa2 and Hnf4α retrovirus for reprogramming to iEPs. On day 20, both samples were sorted
for tdTomato-positive cells by fluorescence-activated cell sorting (FACS) (Fig. S4.2c). After
loading the cells onto 10x Chromium for co-encapsulation with barcoded beads and reverse
transcription, SRTs were selectively amplified from both the undirected and the FOXA2-directed
samples (Fig. S4.2d).
We noted that FOXA2-directed insertions were less numerous than undirected insertions,
producing fewer tdTomato-positive cells and less SRT amplification, although both produced
reprogrammed cells with detectable levels of SRTs. This is in line with previous report of reduced
transposase activity when fused to a TF (Moudgil et al., 2019). As a proof-of-concept, we next
focused on undirected insertions to map active enhancers via PiggyBac transposase’s native
affinity to epigenetic reader BRD4. BRD4 is a ubiquitously expressed transcriptional activator
with kinase activity and histone acetyltransferase activity (Hsu & Blobel, 2017), reported to
localize to lineage-specific enhancers during differentiation (Lee et al., 2017; Najafova et al.,
2017). In the context of reprogramming cell identity, BRD4 is required for the ‘elite-cell’ model
of reprogramming from Bα’ cells to pluripotency via localization to embryonic stem cell-specific
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super-enhancers (Di Stefano et al., 2016). With this, we next sought to investigate the role of
BRD4-bound enhancers in reprogramming to iEPs.

4.4 Simultaneous Assay of Single-Cell Gene Expression and
Active Enhancers in iEP Reprogramming
We previously showed that iEP reprogramming with Foxa1 and Hnf4α is characterized by
distinct successful and ‘dead-end’ trajectories that are determined in the earlier time points. This
trajectory bifurcation occurs by day 13, after which clonally related cells share the same
reprogramming outcome. Examination of clonally related cells split into two independent
biological replicates for reprogramming in parallel revealed that they do not follow the same
trajectory (Biddy et al., 2018). This suggests that reprogramming to iEP is deterministic, but not
due to the existence of ‘elite cells’ that readily reprogram. Given this, what then leads to the
trajectory determination in early reprogramming? To answer this question, we employed scCC to
record active enhancers in the first week of reprogramming, while allowing the cells to continue
in culture so that distinct trajectories could develop, and the differences in enhancer activity
between trajectories could be recorded and analyzed (Fig. 4.2a).
MEFs were electroporated with HyPBase and SRT-tdTomato on day 0, then serially
transduced with Hnf4α-Foxa1-GFP retrovirus over the next 3 days. To track clonal expansion, the
cells were additionally transduced with CellTag Library V1 at the end of the serial transduction.
By day 14, epithelial-like colonies had emerged, where GFP-positive cells from transduction and
tdTomato-positive cells from transposon insertions could be observed (Fig. S4.3a). We sorted for
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tdTomato-positive cells (Fig. S4.3b) for scRNA-seq, following which single-cell gene expression
and SRT libraries were prepared as previously described (Moudgil et al., 2019) (Fig. S4.3c-d).
Analyzing the gene expression library reveals 5927 cells (Fig. S4.3e), with a gradient of
iEP marker Apoa1 expression that opposes that of fibroblast marker Col1a2 (Fig. S4.3f), in line
with previous work (Biddy et al., 2018). From the SRT library, we obtained 15,583 insertions,
from which 181 active enhancer peaks were called as previously described (Moudgil et al., 2019).
Visualization of insertion and peak tracks in the Wash U epigenomic browser (X. Zhou & Wang,
2012) shows that peaks correspond to genomic regions of insertion enrichment (Fig. 4.2b), often
nearby genes of known significance in iEP reprogramming such as pioneer TF Foxa2 and collagen
gene Col3a1 (Fig. S4.3g). Visualizing insertions across the mouse genome reveals a non-uniform,
non-random insertion profile (Fig. 4.2c), in line with previous reports (Gogol-Döring et al., 2016;
Moudgil et al., 2019). The majority of the peaks annotated near promoters, overlapping with other
genomic elements (Fig. 4.2d), perhaps due to the broad nature of super-enhancer-associated peaks
(Whyte et al., 2013).
We next sought to integrate this iEP reprogramming day 14 gene expression data (Fig.
s4.3e) with our previously reported dataset of iEP reprogramming collected from two biological
replicates over multiple time points from day 0 to day 28 (Biddy et al., 2018). Our previous work
showed that reprogramming day 14 is a representative snapshot of the reprogramming process
(Biddy et al., 2018), and integration with a reference dataset can help anchor and reveal the distinct
reprogramming trajectories. We downsampled the reference data to 5927 cells and performed
integration using Seurat v3, resulting in 11 clusters with good overlap between samples (Fig. 4.2ef). Visualization of known markers revealed Col1a2-expressing fibroblasts in clusters 4, 6, and 7
(Figs. S4.4a). Projecting time point (Fig. S4.4b) and trajectory (Fig. S4.4c) metadata onto clusters
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Figure 4.2 Simultaneous capture of cell identity and early active enhancer profiles in iEP reprogramming. (a)
To record enhancer activity in early reprogramming, MEFs were electroporated on day 0 with scCC plasmids, then
serially transduced with reprogramming factors over the next 3 days, along with the CellTag V1 Library on day 4 to
track clonal expansion. The reprogramming cells were cultured for 2 weeks, allowing for distinct trajectories to
develop. On day 14, cells expressing ‘self-reporting’ transcripts were enriched by sorting for tdTomato-positive cells,
which were then processed for scRNA-seq for simultaneous capture of gene expression and SRT readout of early
enhancer activity. (b) An example snapshot of insertion and peak visualization using the Wash U Epigenome Browser,
demonstrating insertion enrichment in areas identified as peaks. (c) Insertion visualization over the whole mouse
genome, showing a non-uniform, non-random insertion profile. (d) Peak annotation to genomic features shows peak
enrichment near promoters, often overlapping with other features. (e) Gene expression integration with an iEP
reference dataset consisting of independent replicates of a 28-day time course confirms good representation of
reprogramming states in the current study. (f) Dimension reduction and clustering by UMAP reveals 11 clusters. (g)
Cluster annotation into different reprogramming states according to metadata projection.

revealed that the reprograming trajectory is comprised of clusters 0 and 3, while the dead-end
trajectory occupies cluster 2 (Figs. S4.4d-e). As such, we annotated the current clustering into
fibroblasts (clusters 4, 6, and 7), early transition (cluster 1), transition (cluster 9), reprogramming
(clusters 0 and 3), and dead-end (cluster 2) (Fig. 4.2g).

4.5 Successful iEP Reprogramming Is Associated with
Activation of Target Tissue-Specific Enhancers
With gene expression clusters annotated, we next sought to analyze the 181 active enhancer
peaks with this information. As each insertion is associated with a cell barcode, we linked the
insertions to reprogramming, dead-end, and fibroblast cell identities based on the associated cell
barcode’s annotation from gene expression. We then performed permutation testing for each
identity’s enrichment in the 181 peaks (Fig. S4.5), and defined subsets of identity-enriched peaks
if a particular peak had a statistically significant enrichment for one identity but not for the others.
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From this, we obtained 25 reprogramming-enriched peaks, 23 dead-end-enriched peaks, and 40
fibroblast-enriched peaks (Fig. 4.3a), which we annotated to their nearest genes (Figs. S4.6-S4.8).
We further analyzed the peak subsets by looking at their association with histone
modifications. As MEFs are prepared by mincing E13.5 embryos after removing the head and gut,
and iEPs are known to functionally engraft liver and colon, we chose to examine ENCODE histone
modification ChIP-seq data from mouse tissues representing the starting and target tissue types,
including post-natal day 0 (P0) liver, P0 intestine, embryonic day 13.5 (E13.5) limb, and E13.5
MEF (Fig. S8) (ENCODE Project Consortium, 2012). Additional ChIP-seq data for E13.5 MEF
were included (Mikkelsen et al., 2007) to supplement the ENCODE data. Intriguingly, we
observed that reprogramming-enriched peaks are associated with liver and intestine H3K27ac, a
histone modification that marks active enhancers, while fibroblast-enriched peaks are associated
with MEF H3K27ac (Fig. 4.3b). In contrast, dead-end-enriched peaks do not correspond to
H3K27ac signal of either starting or target tissues, suggesting that there might be off-target
aberrant enhancer activity in the dead-end trajectory that is not productive to reprogramming
outcome. Together, this suggests that successful reprogramming is accompanied by early
activation of target tissue-specific enhancers, in line with previous work of reprogramming to
induced neurons where rapid occupancy by pioneer TF ASCL1 at canonical neuronal sites were
seen within 48 hours of induction (Wapinski et al., 2013). Reprogramming-enriched peaks are also
associated with moderate but central H3K4me3 signals conserved across several tissues, whereas
fibroblasts-enriched peaks show centrally depleted H3K4me3 signal profiles (Fig. 4.3c). Of note,
while other peaks are generally depleted of repressive signals such as H3K9me3 and H3K27me3
in all tissues examined, reprogramming-enriched peaks are associated with moderate H3K27me3
enrichment in limb (Fig. S4.9a) and MEF (Fig. S4.9b), suggesting that repressive chromatin may
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Figure 4.3 Peak trajectory enrichment analysis reveals association with target tissue-specific enhancers. (a)
Peaks that are statistically significantly enriched with insertions corresponding to a given trajectory are identified by
randomized permutation testing. This reveals 25 reprogramming-enriched peaks, 23 dead-end enriched peaks, and 40
fibroblast-enriched peaks. (b) Examining target and starting tissue histone modification profiles shows that
reprogramming-enriched peaks are associated with H3K27ac in liver and intestine, while fibroblast-enriched peaks
are associated with H3K27ac in MEF. (c) Reprogramming-enriched peaks exhibit moderate but centrally-localized
H3K4me3 signal across starting and target tissue types, while dead-end-enriched and fibroblast-enriched peaks show
centrally depleted profiles. (d) Chromatin state annotations in reprogramming-enriched peak regions, example shown
here for peak 22, tend to correspond to strong enhancer activity in the developing mouse liver.
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remain generally inaccessible, but overcoming the chromatin barrier may be an important event
for successful reprogramming.
We next sought to visualize the peaks alongside previously published chromatin state
annotations in starting and target tissue types (Gorkin et al., 2017). Interestingly, reprogrammingenriched peaks seem to correspond to regions that are annotated as strong enhancers in the
developing liver (Figs. 4.3d and S4.10a), while dead-end-enriched peaks correspond to regions
with strong or permissive transcription in the limb (Fig. S4.10b). On the other hand, fibroblastenriched peaks correspond to regions with active promoter, strong enhancer, and strong
transcription annotations in the limb, while these regions in the developing liver and intestine are
annotated as heterochromatin (Fig. S4.10c), suggesting that fibroblasts that remain as fibroblasts
might be restricted to their fibroblast fate by retaining enhancer activity in these ‘limb-exclusive’
genomic regions.

4.6 Enhancer Activation Is Associated with Distinct
Transcriptional Outcomes
To visualize the association between peaks and gene expression, we projected peak
information onto the gene expression clustering by plotting the contour of cells associated with
each peak subset (Fig. 4.4a). This reveals distinct peak contour patterns that pass through the
transition clusters and concentrates to each peak subset’s corresponding identity. However, there
is also significant overlap between contours, suggesting that a number of enhancers might be nonproductive to reprogramming outcomes.
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Figure 4.4 Cells associated with the identified peak subsets display distinct contour patterns. (a) To further
integrate peak analysis and gene expression visualization, we show here the composite contour profiles of cells
associated with each peak in all three identified peak subsets. (b) Peak 96, one of the reprogramming-enriched peaks
annotated near gene Mbd5, displays a more restrictive contour pattern traversing the transition clusters and
reprogramming clusters. (c) Another ‘restrictive’ pattern reprogramming-enriched peak is peak 101, which is
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annotated near gene Foxa2. (d) Dead-end-enriched peak 50, annotated near gene Isl1. (e) Dead-end-enriched peak 55,
annotated near gene Pcdh9.

Examining individual peak contours reveals some with a more “restrictive” pattern, which
may imply a more deterministic role in reprogramming (Fig. 4.4b-c). For example, peak 96, a
reprogramming-enriched peak near gene Mbd5, has a contour pattern encompassing fibroblast and
transition clusters, with the highest levels over the reprogramming clusters. Mbd5 belongs to a
family of genes encoding nuclear proteins containing a methyl-CpG binding domain (MBD).
Within the MBD family, MBD5 is known to be associated with the PR-DUB Polycomb complex
(Baymaz et al., 2014), and colocalizes with heterochromatin (Laget et al., 2010). Mutations in
MBD5 in human are associated with neurological and developmental defects (Mullegama & Elsea,
2016). Intriguingly, within the MBD family, Mbd3 has been previously studied in the context of
cell identity, where depletion of Mbd3 in embryonic stem cells caused differentiation defect (Kaji
et al., 2006). In the context of cell identity reprogramming, Mbd3 removal resulted in deterministic
and synchronized iPS cell reprogramming with near 100% efficiency (Rais et al., 2013), while
another group reported a context-dependent role of Mbd3 in facilitating induction of pluripotency
(dos Santos et al., 2014).
Another reprogramming-enriched peak of interest is peak 101, annotated near gene Foxa2
(Fig. 4.4c; also see Fig. S4.3g). Developmentally, Foxa1 and Foxa2 share a large overlap in their
expression patterns, most prominently in the endoderm and some regions of the nervous system
(Friedman & Kaestner, 2006). Among the three Foxa genes, Foxa2 has the most severe knock-out
phenotype, with embryonic lethality occurring at E10-11 and severe defects in the nervous system
and gut (Weinstein et al., 1994). Given that the reprogramming in this study was performed with
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Foxa1 and Hnf4α overexpression, enhancer activation near Foxa2 suggests a potentially
cooperative role between the Foxa genes in developmental and reprogramming context.
Interestingly, dead-end-enriched peaks 50 (Fig. 4.4d) and 55 (Fig. 4.4e) annotated near
genes Isl1 and Pcdh9, respectively. Isl1 encodes a pioneer TF involved in cardiogenesis (R. Gao
et al., 2019), and is reported to modulate demethylation of H3K27me3 in cardiac progenitors cells
(Y. Wang et al., 2016). Outside of the heart, Isl1 is known to have roles in specifying motor neuron
(Cho et al., 2014; Ericson, Thor, Edlund, Jessell, & Yamada, 1992; Son et al., 2011; Velasco et al.,
2017) and pancreatic β-cell (Ediger et al., 2014, 2016) identities. Pch9, on the other hand, encodes
a cell adhesion protein expressed in the nervous system (Asahina, Masuba, Hirano, & Yuri, 2012).
These ‘off-target’ tissue gene activation again suggests that aberrant enhancer activity in the deadend trajectory might be responsible for the unproductive reprogramming outcome.
Of note, we detected 140 clones with moderate clonal expansion detected at day 14, in line
with previous observations (Fig. S4.11a). Furthermore, peak subsets examined were not
significantly enriched in particular individual clones (Fig. S4.11b).

4.7 Discussion and Closing Remarks
Here, we demonstrate the application of scCC, a transposase-mediated recording of active
enhancers via PBase’s native affinity to the ubiquitously expressed epigenetic reader BRD4
(Gogol-Döring et al., 2016; Hsu & Blobel, 2017; Moudgil et al., 2019), in a unique system of direct
lineage reprogramming to iEPs. By combining single-cell resolution assay for active enhancers
with gene expression profiling, we showcase here the power of integrating multiple single-cell
modalities for probing complex heterogeneous biological processes such as direct lineage
reprogramming.
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Previous work showed that pioneer TF ASCL1 localizes to its canonical neuronal binding
sites within 48 hours of reprogramming induction (Wapinski et al., 2013), and that rapid chromatin
changes can be seen as soon as 12 hours post induction (Wapinski et al., 2017). In line with this,
we recorded BRD4-binding within the first few days of direct lineage reprogramming iEPs, and
compared early active enhancer profiles between different reprogramming trajectories. We found
that the successful reprogramming trajectory is associated with early activation of liver-specific
enhancers, while cells that remain as fibroblasts still possess activity of MEF-specific enhancers,
suggesting that reprogramming outcome might be determined within the first week. Furthermore,
active enhancers in the reprogramming trajectory are moderately enriched for MEF H3K27me3,
suggesting that overcoming repressive chromatin barrier may be an important feature associated
with successful reprogramming outcome. Given that active enhancers in the dead-end trajectory
and the fibroblasts are depleted of repressive H3K27me3 signal in the starting cell type MEF, and
that our previous work argues against an ‘elite-cell’ population, this study provides some evidence
for an early stochastic-late deterministic model where the repressive chromatin barrier is overcome
in a small minority of cells by chance, which then proceeds to enter the deterministic
reprogramming phase.
The ‘off-target’ enhancer activity associated with dead-end-enriched peaks, corresponding
to genes implicated in the development of other tissue types, is an interesting finding that provides
evidence for the promiscuous model of pioneer TF binding driving aberrant gene activation that is
unproductive to reprogramming outcome. Together with the repressive chromatin context, this
may represent additional roadblocks for efficiency cell identity specification, and points to an
important area of consideration for the improvement of cell engineering strategies.
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This study is limited by its preliminary scale and relatively shallow sampling of BRD4
binding. Furthermore, active enhancer profiling is a secondary readout of TF activity orchestrating
the GRN changes that ultimately lead to cell identity switching. FOXA, the pioneer TF employed
in this direct lineage reprogramming strategy, is known have the capacity to bind compacted
nucleosomal chromatin, but also exhibits tissue-specific enhancer occupancy in its native tissue as
well as when ectopically expressed (Donaghey et al., 2018; Iwafuchi-Doi et al., 2016). An
important future challenge would be to use TF-directed scCC assay to uncover FOXA binding
differences between trajectories and the molecular mechanisms underlying the trajectory
bifurcation for improving the efficiency and specificity of cell identity reprogramming.

4.8 Materials and Methods
4.8.1 Cell Culture
Mouse embryonic fibroblasts were derived from the C57BL/6J strain (The Jackson
Laboratory 000664). HEK293 and mouse embryonic fibroblasts were cultured in Dulbecco’s
Modified Eagle Medium (Gibco) supplemented with 10% Fetal Bovine Serum (Gibco), 1%
penicillin/streptomycin (Gibco), and 55 μM 2-mercaptoethanol (Gibco).

4.8.2 Transfection
HEK293 cells were transfected using X-tremeGENE 9 (Sigma-Aldrich). Briefly, for each
replicate, approximately 500,000 HEK293 cells were transfected with 3 μL of X-tremeGENE 9,
0.5 μg of helper plasmid (pCS2-Foxa2-HyPBase or pCS2-HyPBase), and 0.5 μg of donor plasmid
(SRT-Puro). 24 hours after transfection, 1 μg/mL puromycin was added to the culture media for
selection, which was replenished on day 3 and removed on day 5.
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4.8.3 Bulk RNA Extraction and Bulk Calling Card Library Generation
Bulk RNA Calling Card libraries were prepared following a previously described protocol
with modifications (Moudgil et al., 2019). Briefly, to recover self-reporting transcripts mapping
FOXA2-directed and undirected insertions, RNA was isolated in bulk from transfected HEK293
cells with RNeasy Mini Kit (QIAGEN). Cells in each replicate were directly lysed in 350 μL of
Buffer RLT supplemented with 1% 2-mercaptoethanol. Then, 350 μL of 70% ethanol was added,
after which 700 μL of the lysate was run through an RNeasy spin column, followed by washing as
directed by the manufacturer’s protocol. RNA was eluted in 30 μL of RNase-free water, then
quantified on a NanoDrop Microvolume Spectrophotometer (Thermo Fischer Scientific).
Then, cDNA synthesis was performed with Maxima H Minus RT Reverse Transcriptase
(Thermo Fischer Scientific), using 2 μg of RNA as input, with 1 μL of 10 nM dNTPs, 1 μL of 50
μM SMART-dT18VN primer (Moudgil et al., 2019), and H2O to bring the total volume to 14.5
μL. The reaction was incubated at 65 °C for 5 minutes, followed by incubation on ice for 1 minute,
after which 4 μL of 5X Maxima RT Buffer and 0.5 μL of Maxima H Minus Reverse Transcriptase
diluted in 1X RT Buffer (100 U) were added to the reaction. The reaction was incubated at 50 °C
for 60 minutes, then 85 °C for 10 minutes. The cDNA products were then stored at -20 °C.
The self-reporting transcripts were amplified from the cDNA by mixing 1 μL of cDNA
product with 12.5 μL Kapa HiFi HotStart ReadyMix (Kapa Biosystems), 0.5 μL of 25 μM SMART
primer, 0.5 μL of 25 μM of SRT_PAC_F1 primer (Moudgil et al., 2019), and 10.5 μL of H2O.
Thermocycling conditions were as follows: 95 °C for 3 minutes; 20 cycles of: 98 °C for 20 seconds,
65 °C for 30 seconds, 72 °C for 5 minutes; 72 °C for 10 minutes; hold at 10 °C forever.
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The PCR products were purified using AMPure XP beads (Beckman Coulter), by adding
15 μL of beads to 25 μL of PCR product, followed by 5-minute incubation at room temperature.
The solution was then placed on a magnetic rack for 2 minutes, then the supernatant was aspirated
and discarded. The pellet was washed with 200 μL of 70% ethanol, incubating for 30 seconds,
followed by supernatant aspiration; this was then repeated for a total of 2 washes. Prior to elution,
the pellet was air-dried for approximately 5 minutes, followed by addition of 11 μL of H2O and
incubation at room temperature for 2 minutes. The mixture was placed on a magnetic rack for 1
minute, then the supernatant was transferred to a clean tube. DNA concentration was measured
using the Qubit 3.0 Fluorometer (Thermo Fisher Scientific) with the dsDNA High Sensitivity
Assay Kit.
Final bulk Calling Card libraries for sequencing were generated with the Nextera XT DNA
Library Preparation Kit (Illumina). Briefly, 240 pg of DNA from the purified PCR product was
resuspended in 2 μL of H2O. Then, 4 μL of Tagment DNA (TD) Buffer and 2 μL of Amplicon
Tagment Mix (ATM) were added to the solution, pipetting to mix. The reaction was incubated at
55 °C for 5 minutes. Then, 2 μL of Neutralization Buffer (NB) was added to the reaction, pipetting
to mix, followed by incubation at room temperature for 5 minutes. Then, to each reaction, we
added 6 μL of Nextera PCR Mastermix (NPM), 3.2 μL of H2O, 0.4 μL of 10 μM forward primer
(OM-PB barcoded transposon primers), and 0.4 μL of 10 μM reverse primer (Nextera N701
indexed primers). Each replicate was assigned to a unique combination of a barcoded transposon
primer and an indexed N7 primer, as previously described (Moudgil et al., 2019). The PCR
reaction was performed with the following thermocycling conditions: 95 °C for 30 seconds; 13
cycles of: 95 °C for 10 seconds, 50 °C for 30 seconds, 72 °C for 30 seconds; 72 °C for 5 minutes;
hold at 10 °C forever. To streamline the following purification step, every 5 PCR products were
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pooled together into 100 μL libraries, as the individual libraries were labeled with unique
combinations of primer barcodes and N7 indexes. The pooled libraries were purified by adding 60
μL of AMPure XP beads, with the subsequent steps as described above. The final libraries were
eluted in 11 μL ofH2O and quantified on an Agilent TapeStation 2200 System using the High
Sensitivity D5000 ScreenTape and reagents (Agilent). The Bulk Calling Card Libraries were
sequenced on an Illumina Mi-Seq.

4.8.4 Electroporation
Mouse embryonic fibroblasts were electroporated using the Neon Transfection System
(Thermo Fisher Scientific). Briefly, MEFs were resuspended in Resuspension Buffer R to a
concentration of approximately 300,000 cells per 100 μL, then electroporated in the 100-μL Neon
reaction tip, under the following condition: 1350 V, 30 ms, 1 pulse. For expression window
analysis, 3 μg of pCS2-dsRed was electroporated into MEFs. For FOXA2-directed scCC pilots, 3
μg of helper plasmid (pCS2-Foxa2-HyPBase or pCS2-HyPBase) and 3 μg of donor plasmid (SRTtdTomato) were electroporated into MEFs. For undirected scCC experiments, 2 μg of helper
plasmid (pCS2-HyPBase) and 10 μg of donor plasmid (SRT-tdTomato) were used.

4.8.5 Lenti- and Retrovirus Production
Lentiviruses were produced by transfecting a 10-cm dish of approximately 5 million
HEK293T cells with 2 μg of CellTag V1 Library ((Biddy et al., 2018) and packing plasmids
pCMV-dR8.2 dvpr (2 μg, Addgene plasmid 8455) and pCMV-VSV-G (200 ng, Addgene plasmid
8454) with 25 μL of X-tremeGENE 9 (Sigma-Aldrich). Retroviruses were similarly produced,
with retroviral pGCDNSam vector and packaging plasmid pCL-Eco (Imgenex). Virus-containing
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supernatant was collected from virus-producing HEK293T cells 48 and 72 hours after transfection,
kept at 4 °C and used within one week. Prior to transduction, protamine sulfate (Sigma-Aldrich)
was added to the viral solution to a final concentration of 4 µg/ml.

4.8.6 Generation of iEPs
Mouse embryonic fibroblasts were converted to iEPs as previously described (Biddy et al.,
2018; Morris et al., 2014; Sekiya & Suzuki, 2011). Briefly, MEFs were prepared from E13.5
embryos and cultured on gelatin. On day 0, approximately 300,000 MEFs were electroporated with
scCC plasmids, then plated back on gelatin-coated 10-cm dish. On days 1-3, the cells were serially
transduced every 12 hours with Hnf4α-t2a-Foxa1 retrovirus for 5 times, followed by transduction
with CellTag V1 virus on day 4 for 24 hours. On day 5, the culture medium was switched to
hepato-medium, which is DMEM:F-12 (Gibco) supplemented with 10% FBS, 1%
penicillin/streptomycin, 55 μM 2-mercaptoethanol, 10 mM nicotinamide (Sigma-Aldrich), 100
nM dexamethasone (Sigma-Aldrich), 1 μg/mL insulin (Sigma-Aldrich), and 20 ng/ml epidermal
growth factor (Sigma-Aldrich). On day 7, the cells were passaged onto collagen-coated dish and
cultured in hepato-medium.

4.8.7 Fluorescence-Activated Cell Sorting
Cells were digested with TrypLE Express (Thermo Fischer Scientific) for 5 minutes at
37 °C, neutralized with culture medium, then washed twice with 1 mL of PBS with 0.5% Bovine
Serum Albumin (Sigma-Aldrich) (PBS/BSA). The cells were resuspended in 0.5 mL of PBS/BSA,
then sorted on a modified Beckman Coulter MoFlo for the tdTomato-positive population.
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4.8.8 Single-Cell RNA-Sequencing and Library Preparation
10x Chromium Single Cell 3’ Library & Gel Bead Kit v2, 10x Chromium Single Cell 3’
Chip kit v2, and 10x Chromium i7 Multiplex kit (10x Genomics) were used according to the
manufacturer’s protocols with the following modifications for scCC library, as previously
described (Moudgil et al., 2019):
Briefly, prior to co-encapsulation with barcoded gel beads, a custom Single Cell Master
Mix was prepared by leaving out the 10x RT Primer, and replacing it with equal-volume IDTE
buffer (Integrated DNA Technologies). At the end of Post GEM-RT cleanup, elution was
performed with 36.5 μL of Elution Solution I, from which 36 μL of elution product was split into
two 18-μL aliquots. One aliquot was immediately processed for generating the single-cell gene
expression library, while the other aliquot was stored at -20 °C until further processing for
generating the scCC library.
For the single-cell gene expression library, a custom step was next performed to add RT
primer sequence back to the RT product, as follows: an RT reaction solution was made with 20 μL
of Maxima 5X RT Buffer, 20 μL of 20% w/v Ficoll PM-400, 10 uL of 10 mM dNTPs, 2.5 μL
RNase Inhibitor, and 2.5 μL of 10x RT Primer 10x RT Primer (template switch oligo). Then, 18
μL of the aliquot was added to the solution, along with 22 μL of ddH2O. Finally, 5 μL of Maxima
H Minus Reverse Transcriptase was added. This reaction was incubated at 25 °C for 30 minutes,
followed by 50 °C for 90 minutes, and heat inactivation at 85 °C for 5 minutes. Next, the solution
was purified using DynaBeads MyOne Silane, following 10x Genomics’ protocol starting at “2.1
Post GEM-RT Cleanup”, step d. The remainder of the single-cell gene expression library
preparation followed 10x Genomics’ protocol.
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The scCC library was generated as previously described (Moudgil et al., 2019). Briefly, 9
μL of the 18-μL aliquot was used while the other half was stored in reserve. Self-reporting
transcripts were amplified using biotinylated primers, purified with AMPure XP beads at 0.6x ratio,
and quantified on Agilent TapeStation 4200 using the High Sensitivity D5000 ScreenTape
(Agilent). The amplified and purified products were circularized overnight using the Nextera Mate
Pair Sample Prep Kit (Illumina), then sheared on a Covaris E220 Focused-ultrasonicator, followed
by custom adaptor ligation and amplification, as previously described (Moudgil et al., 2019).
Single-cell gene expression library was sequenced on Illumina HiSeq 2500, while scCC
library was sequenced on Illumina NextSeq 500 with custom priming, as previously described
(Moudgil et al., 2019).

4.8.9 Peak Calling
For FOXA2-directed insertions in HEK293 cells, peaks were called as follows: raw reads
were mapped back to the human genome (hg38) with Bowtie2, then significant peaks were called
with a modified version of the previously described algorithm (H. Wang et al., 2012). Briefly,
transposon insertions were clustered into peaks with a maximum distance of 5 kb between
insertions. Significant peaks were identified using the Poisson distribution to test for enrichment
over the background (unfused transposase) Calling Card data. The expected number of hops per
TTAA was locally estimated from the background Calling Card data by considering regions
centered directly under the Calling Card peak, 1 kb from the Calling Card peak, or 5 kb from the
Calling Card peak, and taking the maximum of the three estimated parameters.
For undirected scCC insertions in reprogramming to iEPs for mapping active enhancers,
peaks were called as previously described (Moudgil et al., 2019). Briefly, raw reads were filtered
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by removing those without the “GGTTAA” PiggyBac terminal repeat-insertion site motif, then
trimmed to remove the P7 adaptor sequence, followed by alignment using the10x Genomics’ Cell
Ranger pipeline, which generated a cell barcode-insertion matrix. Then, significant BRD4 binding
sites from undirected insertions were called, by segmentation into Bayesian blocks and calculating
the Poisson p-value for each block, given the observed number of insertions, and the expected
number of insertions assuming uniform distribution across the genome. A p-value cutoff of 10-9
was used to find significant blocks, which were then processed by merging blocks that were within
12,500 bases of each other.

4.8.10 Peak Annotation and Motif Analysis
Peaks were annotated to their nearest genes and visualized using R package ChIPseeker
(G. Yu, Wang, & He, 2015), while insertion profile was visualized using R package karyoploteR
(Gel & Serra, 2017). The Wash U Epigenome Browser was used to visualize insertion and peak
tracks together (X. Zhou & Wang, 2012). For FOXA2 peaks, de novo motif discovery and known
motif enrichment analysis were performed using HOMER’s findMotifsGenome function using the
following parameters: hg38 -p 4 -S 5 (Heinz et al., 2010). The analysis for FOXA2 motif
enrichment in peaks was performed with the annotatePeaks fuction, using homer’s motif file for
FOXA2, with the following parameters: hg38 -size 1000 -m homer/motifs/foxa2.motif. The result
was then visualized in R using ggplot2.

4.8.11 Analysis of Single-Cell Gene Expression
For single-cell gene expression, reads were analyzed using 10x Genomics’ Cell Ranger
pipeline. The R package Seurat (Version 3) was used for data processing, integration, and
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visualization (Butler et al., 2018). The reference iEP single-cell gene expression dataset (Biddy et
al., 2018) was processed for integration by regressing out the following variables to minimize
technical variations: number of transcripts, number of genes, percentage of transcript count
attributed to mitochondrial genes, cell cycle phase, and replicate, using the sctransform feature in
Seurat V3 (Butler et al., 2018; Stuart et al., 2018). The day 14 iEP gene expression dataset
generated from this study was processed similarly, by assigning cell cycle using R package scran
(Lun, McCarthy, & Marioni, 2016), removing cells with a low number of genes detected (<200),
cells with a high number of genes detected (>5000), and cells with a high proportion of transcripts
attributed to mitochondrial genes (>5%), followed by regressing out the following variables:
number of transcripts, number of genes, percentage of transcript count attributed to mitochondrial
genes, and cell cycle phase. For integration, the reference dataset was down-sampled to the same
number of cells as the current dataset, then integrated with the current dataset, as described (Stuart
et al., 2018). Linear dimension reduction was then performed, followed by clustering and
visualization via UMAP (Becht et al., 2019).

4.8.12 Assessing Trajectory Enrichment in Peaks by Randomized Testing
A modified version of our previously developed randomized testing method (Biddy et al.,
2018) was used to identify peaks that are significantly enriched with the following reprogramming
trajectories of interest: reprogramming trajectory, dead-end trajectory, or fibroblasts. Briefly, we
calculated the proportions of reprogramming-, dead-end-, and fibroblast-associated insertions that
fall into each peak, which were then defined as the null percentage for each trajectory. Specifically,
for each trajectory independently, let n be the number of insertions with this trajectory annotation,
let s be the number of insertions without this annotation. The two were then pooled together, from

94

which we drew n random samples without replacement for at least (n+s)/n times such that every
possible ending group can be captured. With each sample drawn, the corresponding trajectory
enrichment proportion within the n sampled insertions in each peak was calculated. A background
proportion distribution was then generated based on this resampling. We then used this distribution
to calculate the p-value for each peak, representing the likelihood of having a proportion equal to
or higher than the null percentage. Using a p-value of <0.05, we identified the peaks that are
statistically significantly enriched for each trajectory. This randomized test was performed using
a python script. Insertion number tested for reprogramming = 1687. Insertion number tested for
dead-end = 1177. Insertion number tested for fibroblast = 641. For visualization, enrichment scores
were calculated by negative base 10 logarithmic of the p-value plus 10-4, for handling floatingpoint accuracy.

4.8.13 ChIP-seq and Chromatin State Analysis
Bigwig files were downloaded from the ENCODE portal (C. A. Davis et al., 2018) for
H3K27ac, H3K4me1, H3K4me3, H3K9me3, H3K27me3, and H3K36me3 ChIP-seq in postnatal
day 0 liver (identifiers: ENCFF734CDU, ENCFF323FCP, ENCFF615IVU, ENCFF040LFN,
ENCFF633GEF, ENCFF555EBK), postnatal day 0 intestine (ENCFF512TCI, ENCFF028YVD,
ENCFF115TVW, ENCFF363IUI, ENCFF133XFD, ENCFF085HHF), and embryonic day 13.5
limb (ENCFF402FVP, ENCFF255RIU, ENCFF856ZXY, ENCFF577WZP, ENCFF779RNO,
ENCFF769VJF). For embryonic day 13.5 MEF, H3K27ac, H3K4me1, and H3K4me3 ChIP-seq
data were available and downloaded from the ENCODE portal (identifiers: ENCFF387JGJ,
ENCFF353PNU, ENCFF379VFT), while H3K9me3, H3K27me3, and H3K36me3 ChIP-seq data
were obtained from a separate work (Mikkelsen et al., 2007), accessed at the ExPASy
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Bioinformatics

Resource

Portal:

https://ccg.epfl.ch/chipseq/chip_seq_wig.html.

Matrix

computation, heatmap generation, and summary plot generation were done on the Galaxy instance
of deepTools: http://deeptools.ie-freiburg.mpg.de (Afgan et al., 2018; Ramírez, Dündar, Diehl,
Grüning, & Manke, 2014), using the ‘reference-point’ mode for computeMatrix, with ‘center of
region’ as the reference point, and ‘10000’ as the distance upstream and downstream of the
reference point defined as the region for plotting.
For visualization and analysis of chromatin state data, we used the epilogos browser
(https://epilogos.altiusinstitute.org) to visualize previously annotated chromatin states in the
developing mouse embryo (Gorkin et al., 2017) in peak regions of interest.

4.8.14 Clonal Analysis
CellTag read processing and clonal analysis were performed using an alpha test version of
R package CellTagR, currently being developed by the Morris lab for future release under our
GitHub repository (https://github.com/morris-lab). Briefly, reads containing the CellTag sequence
were extracted from the processed and filtered BAM file produced by 10x Genomics’ Cell Ranger
pipeline, followed by removal of cells that were not present in the filtered Cell Ranger output files.
Then, the cell barcode-CellTag count matrix was generated. The CellTag sequences were
collapsed on a cell-by-cell basis using Starcode, after which the count matrix was collapsed
accordingly and binarized for downstream processing. The binarized matrix was filtered by
‘whitelist’-based filtering, only keeping CellTag sequences known to be present in the V1 Library,
and metric-based filtering, removing cells expressing less than 2 or more than 20 CellTags. Finally,
Jaccard analysis was performed to call clones of related cells, using a cutoff of >0.7. Visualization
was then performed by passing clone ID as metadata into the Seurat object.
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Figure S4.1 Analysis of FOXA2-directed insertions of SRT in HEK293 validates RNA Calling Cards approach
for profiling TF binding. (a) Genomic feature annotation of the 9867 FOXA2 peaks called, showing enrichment for
intro and intergenic regions. (b) FOXA2 peaks are moderately enriched around transcription start sites (TSS). (c) de
novo, and (d) known motif analysis from 9867 peaks. (e) The FOXA2 motif is enriched in peaks around TSS.
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Figure S4.2 scCC is feasible for utilization in reprogramming fibroblasts to iEPs. (a) Electroporation of a dsRed
plasmid into MEFs shows that transfected plasmids in fibroblasts are transiently expressed, with maximal expression
around days 1-2, quantified in (b). (c) Electroporation of scCC plasmids into MEFs that were subsequently
reprogrammed with Foxa2 and Hnf4α, then collected on day 20, shows that tdTomato+ cells expressing the inserted
SRTs can be enriched from both the undirected and the FOXA2-directed conditions. (d) After co-encapsulation and
reverse transcription with barcoded beads for scRNA-seq, SRTs can be selectively amplified from both the undirected
and FOXA2-directed samples, showing a peak size around ~1000 bp.
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Figure S4.3 Recording early active enhancers in iEP reprogramming via undirected scCC. (a) Brightfield and
fluorescent images of day 14 iEPs reprogrammed from MEFs electroporated with undirected scCC plasmids, showing
GFP+ and tdTomato+ cells corresponding to viral transduction and SRT expression. (b) On day 14, cells were FACSsorted for tdTomato+ population, which constitutes 44% of the sorted cells. (c) For scCC library preparation, ‘selfreporting’ transcripts were amplified from the RT product from single-cell co-encapsulation with barcoded beads. (d)
The final scCC library was generated after circularization, junction capture, and final adaptor ligation and
amplification. (e) Single-cell gene expression of the day 14 cells, showing 13 clusters after dimension reduction and
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clustering by UMAP. (f) Day 14 cells express a gradient of known reprogramming markers. (g) Wash U Epigenome
Browser visualization of insertion and peak profiles, showing peaks near known genes of interest in reprogramming,
such as reprogramming factor Foxa2 and collagen gene Col3a1.
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Figure S4.4 Day 14 gene expression integration with reference dataset reveals reprogramming trajectories. (a)
Integrated gene expression showing iEP markers Apoa1 and Cdh1, fibroblast marker Col1a2, reprogrammingtransition marker Mettl7a1, and dead-end markers Fzd1 and Peg3. (b) Time point metadata projection shows that
reprogramming progression coincides with time progression, with day 14 of this study representing a snapshot of all
reprogramming stages; (c) Projecting trajectory annotation from the reference data reveals the distribution of
reprogramming and dead-end paths. (d) Dead-end cells occupy cluster 2, while reprogramming cells occupy clusters
0 and 3. (e) Density plots of dead-end and reprogramming cells visualizing trajectory distribution.
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Figure S4.5 Permutation testing of trajectory enrichment identifies peak subsets. Enrichment scores are plotted
for each trajectory tested for all peaks, corresponding to (a) reprogramming enrichment, (b) dead-end enrichment, and
(c) fibroblast enrichment.
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Figure S4.6 Reprogramming-enriched peaks.
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Figure S4.7 Dead-end-enriched peaks.
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Figure S4.8 Fibroblast-enriched peaks.
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Figure S4.9 Peak association with tissue-specific histone modifications. (a) ENCODE histone modification data
for H3K27ac, H3K4me1, H3K4me3, H3K9me3, H3K27me3, and H3K36me3 were obtained for P0 liver, P0 intestine,
and E13.5 limb. ENCODE histone modification data for H3K27ac, H3K4me1, and H3K4me3 were obtained for E13.5
MEF. (b) E13.5 MEF H3K9me3, H3K27me3, and H3K36me3 data were obtained from Mikkelsen et al. Summary
plots shown here display corresponding signal mean for each peak subset, with heatmaps showing peak regions sorted
by descending signal mean.
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Figure S4.10 Additional examples of chromatin state annotations in peak subsets. (a) Reprogramming-enriched
peak 163 shows active enhancer annotations in E12.5 to P0 liver. (b) Dead-end-enriched peaks 94 and 109 show
strong or permissive transcription in E11.5 to E15.5 limb. (c) Fibroblast-enriched peaks 12 and 106 have annotations
of active promoter, strong enhancer, and strong transcription in E11.5 to E15.5 limb, while these regions receive
heterochromatin annotations in E12.5 to P0 liver and E14.5 to P0 intestine.
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Figure S4.11 Clonal analysis reveals 140 clones with moderate clonal expansion. (a) Pairwise correlation scores
(Jaccard similarity) and hierarchical clustering of 140 clones detected in this experiment. Table showing clone ID and
size. (b) Examples of individual peak contours visualizing clonal relationship by color. No significant clonal
enrichment was found.
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